Instituto Aragonés de Ciencias de la Salud

Memoria
Científica

3
4

I+CS

2010
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD
Avda. Alcalde Gómez Laguna, 25 Planta 3
50009 Zaragoza
Tel. 976 71 58 95
Fax: 9...
ÍNDICE
1.

Introducción .....................................................................................................
1

In trod ucci ón
1. Introducción
Esta Memoria presenta la actividad científica desarrollada a lo largo del año 2010 en el Instituto Aragoné...
sido potenciadas a través de convenios firmados con entidades a nivel regional y nacional (PAMER, AWHS,
SALUD, farmaindust...
2

In dic ado res d e Prod ucc ión C ie n tífi ca
2. Indicadores de Producción Científica

Metodología
Las publicaciones se presentan agrupadas por hospital / centro. Se ha...
Tabla 1.1. Indicadores de producción científica
Indicador

Cálculo

Resultado

231/354

0,65

1.383,884

1.383,884

Factor...
Figura 1.1: Publicaciones por cuartiles

CUARTIL 4
18%

CUARTIL 1
38%

CUARTIL 3
17%

CUARTIL 2
27%

Figura 1.2: Factor de...
Las áreas temáticas con un mayor factor de impacto son oncología, digestivo, genética e ingeniería
biomédica seguidas de h...
Figura 1.5: Factor de impacto por centro

H Royo Villanova
35,003

Atención Primaria
20,665
Resto 32,98

H Barbastro 55,49...
3

Re lac ió n de ar tícu los

14
3.

Relación de artículos

Atención Primaria

FI: 20,665

A continuación se relacionan los artículos con factor de impacto...
MMB;Irigoyen EC;Abella MC;Pinilla M;Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications:...
3.1.11

Neurociencias

Gracia-Naya M;Huerta-Villanuev M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa ...
3.1.18
Arnal

Urología y Nefrología
LML;Gutierrez

AS;.Prevalence

of

BC;Izquierdo
chronic

kidney

MC;Garcia

OG;Alcaine...
Garcia-Gil FA;Lampreave F;Fuentes-Broto L;Carpintero R;Gonzalvo E;Garcia JJ;varez-Alegret R;Alfaro J;Orden I;Roda L;.Inter...
Dignass A;Van Assche G;Lindsay JO;Lemann M;Soderholm J;Colombel JF;Danese S;D'Hoore A;Gassull M;Gomollon F;Hommes
DW;Miche...
3.1.27

Endocrinología y Metabolismo

Chedraui P;Perez-Lopez FR;Blumel JE;Hidalgo L;Barriga J;.Hyperglycemia. in postmenop...
Mateos MV;Oriol A;Martinez-Lopez J;Gutierrez N;Teruel AI;de Paz R;Garcia-Larana J;Bengoechea E;Martin A;Mediavilla
JD;Palo...
3.1.37

Neurociencias

Gracia-Naya M;Huerta-Villanueva M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa...
Rodriguez-Galietero A;Martinez JVG;Del Buey A;Bescos JAC;.Use of Brimonidine Before LASIK With Femtosecond Lasercreated Fl...
Martin-Broto J;Gutierrez A;Garcia-del-Muro X;Lopez-Guerrero JA;Martinez-Trufero J;de Sande LM;Lainez N;Maurel J;De Juan
A;...
3.1.43

Radiología, Medicina Nuclear y Diagnóstico por imagen

Andres A;Tardin L;Santapau A;Razola P;Prats E;Parra A;Rivas...
Lobo E;Dufouil C;Marcos G;Quetglas B;Saz P;Guallar E;Lobo A;.Is There an Association Between Low-to-Moderate Alcohol
Consu...
3.1.54

Oncología

Roca JM;Alonso V;Pericay C;Escudero P;Salud A;Losa F;Lopez LJ;Guasch I;Mendez M;Quintero-Aldana G;Grand...
3.1.62

Medicina Interna

Almagro P;Garcia FL;Cabrera FJ;Montero L;Morchon D;Diez J;de la Iglesia F;Roca FB;Fernandez-Ruiz...
Sole-Violan J;de Castro FR;Garcia-Laorden MI;Blanquer J;Aspa J;Borderias L;Briones ML;Rajas O;Carrondo IML;Marcos-Ramos
JA...
3.1.77

Respiratorio

Borderias L;Morell F;Vera J;Briz H;Munoz X;Cruz MJ;.Starling-Induced Hypersensitivity Pneumonitis: M...
3.1.85

Bioquímica y biología molecular

Martin P;Pardo J;Schill N;Jockel L;Berg M;Froelich CJ;Wallich R;Simon MM;.Granzym...
Delgado JF;Crespo-Leiro MG;Gomez-Sanchez MA;Paniagua MJ;Gonzalez-Vilchez F;de Prada JAV;Fernandez-Yanez J;Pascual
D;Almena...
Biegstraaten M;Mengel E;Marodi L;Petakov M;Niederau C;Giraldo P;Hughes D;Mrsic M;Mehta A;Hollak CEM;van Schaik
IN;.Periphe...
3.1.95

Inmunología

Gutierrez-Dalmau A;Revuelta I;Ferrer B;Mascaro JM;Oppenheimer F;Albanell J;Campistol JM;.Distinct Imm...
Pascual-Gomez J;Gracia-Naya M;Leira R;Mateos V;varo-Gonzalez LC;Hernando I;Oterino A;Iglesias-Diez F;Caminero A;GarciaMonc...
3.1.101 Oncología
Anton A;Lluch A;Casado A;Provencio M;Munoz M;Lao J;Bermejo B;Paules AB;Gayo J;Martin M;.Phase I Study of...
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Memoria científica IACS 2010
Upcoming SlideShare
Loading in …5
×

Memoria científica IACS 2010

1,616 views

Published on

Memoria científica del Instituto Aragonés de Ciencias de la Salud 2010

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,616
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Memoria científica IACS 2010

  1. 1. Instituto Aragonés de Ciencias de la Salud Memoria Científica 3 4 I+CS 2010
  2. 2. INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD Avda. Alcalde Gómez Laguna, 25 Planta 3 50009 Zaragoza Tel. 976 71 58 95 Fax: 976 71 46 70 www.ics.aragon.es
  3. 3. ÍNDICE 1. Introducción ............................................................................................................................................ 6 2. Indicadores de Producción Científica ................................................................................................... 9 3. Relación de artículos ............................................................................................................................ 15 4. Política de personal .............................................................................................................................. 54 5. Servicios de Apoyo Común.................................................................................................................. 57 6. Acciones estratégicas .......................................................................................................................... 73 7. Formación.............................................................................................................................................. 77 8. Espacios de investigación ................................................................................................................... 82
  4. 4. 1 In trod ucci ón
  5. 5. 1. Introducción Esta Memoria presenta la actividad científica desarrollada a lo largo del año 2010 en el Instituto Aragonés de Ciencias de la Salud por el conjunto de centros asistenciales del Sistema Público de Salud de Aragón y por investigadores y grupos de la Universidad de Zaragoza Refleja la experiencia acumulada que, paso a paso, se ha ido adquiriendo desde hace años en esta Comunidad y que se ha intensificado en los últimos, desde la creación del Instituto Aragonés de Ciencias de la Salud. Los Planes Científico y Estratégico de este Instituto plantean nuevos retos centrados en la consolidación y proyección a nivel nacional e internacional de sus grupos de investigación y del propio Instituto. Son retos inmediatos la definición de áreas científicas prioritarias -aquellas con especial potencial de generar conocimiento científico de excelencia-, la puesta en marcha de medidas que permitan su consolidación y crecimiento y el apoyo simultáneo a otras áreas y grupos que, a día de hoy, emergen con fuerza en el panorama de la investigación en salud en Aragón. Durante 2010 hemos visto cómo la actividad científica global aumenta día a día, cualitativa y cuantitativamente, a la vez que se van concentrando y perfilando áreas temáticas de excelencia científica. Las líneas clínicas de investigación en enfermedades del aparato digestivo, enfermedades cardiovasculares, oncológicas, hematológicas, de salud mental, de pediatría, respiratorias y oftalmológicas son algunos buenos ejemplos de ello. A ellas se suman otras de carácter transversal, como salud pública e investigación en servicios sanitarios, ingeniería biomédica o la medicina regenerativa. En términos de producción científica, en 2010 ha habido un incremento con respecto al año 2009. Y este crecimiento, además, se concentra especialmente en Áreas como patología digestiva, cáncer o ingeniería biomédica. 2010 ha sido un año decisivo en cuanto al impulso y coordinación de infraestructuras científicas. La acción conjunta de investigadores y los órganos de gestión científica del Instituto ha permitido la incorporación a plataformas de investigación relevantes a nivel nacional y con decidida proyección internacional como CAIBER o a la Red Nacional de Biobancos. La potenciación y consolidación de unos servicios de apoyo comunes de primer nivel ha sido una de las acciones estratégicas fundamentales del Instituto durante 2010. Buenos ejemplos de ello es la oferta actual de servicios de este Instituto en el campo de: genómica, proteómica, separación celular y citometría, cultivo celular, microscopía e imagen, anatomía patológica, valoración funcional de animales, transgénesis, cirugía experimental, estabulario, separación celular y secuenciación de ADN, apoyo metodológico, documentación, apoyo a la investigación clínica o biobanco. Algunas acciones científicas especialmente relevantes han sido el desarrollo del Programa Aragonés de Medicina Regenerativa, una línea estratégica que, durante 2010, verán la luz los primeros trabajos científicos en publicaciones internacionales de primer nivel liderados por investigadores de esta Comunidad. Otros ejemplos de grandes proyectos, consolidados durante este período, han sido el Estudio de Cohorte AWHS (Aragon Worker´s Health Study) o una infraestructura de investigación para seguimiento y evaluación de las acciones emprendidas en el contexto del Plan de Prevención de Cáncer Colorrectal. Ambas acciones suponen plataformas sólidas y con capacidad, por si solas, de generar nuevo conocimiento científico y han 6
  6. 6. sido potenciadas a través de convenios firmados con entidades a nivel regional y nacional (PAMER, AWHS, SALUD, farmaindustria, etc). Pero, sobre todo, la captación y retención de talentos es crucial para el futuro. En este sentido el Instituto está haciendo un importante esfuerzo dirigido a la incorporación de jóvenes investigadores en las primeras etapas de su carrera profesional, y de investigadores Miguel Servet y ARAID, con trayectoria investigadora contrastada y que constituyen el germen de nuevos grupos de investigación. En 2010 se han incorporado dos nuevos investigadores Miguel Servet y se ha obtenido la valoración favorable para otros dos nuevos investigadores Miguel Servet y ARAID cuya incorporación está prevista en 2011. Asimismo el Instituto Aragonés de Ciencias de la Salud ha promovido la intensificación de profesionales sanitarios, favoreciendo el desarrollo de su actividad científica, un total de 9 profesionales cuentan, en este momento con una liberación parcial de su actividad asistencial y 2 con una liberación total para el desarrollo de sus respectivas líneas de investigación. De forma complementaria, nuestro Plan de Formación en Investigación potencia la trayectoria investigadora de los jóvenes talentos, que se forman y enriquecen en los grupos de investigación del Instituto. Asimismo, la realización de jornadas científicas y seminarios, así como cursos de alto nivel destinados a investigadores senior completa la oferta formativa del Plan de Formación potenciando la investigación de excelencia. Conocer bien cuáles son nuestras fortalezas y las oportunidades del entorno ha permitido la incorporación de un nutrido grupo de personas tanto investigadores como personal de apoyo, que han permitido, además, mantener la tendencia creciente en cuanto a la creación de nuevos grupos de investigación. Son ellos los que han permitido que este Instituto se sitúe, de nuevo en 2010, entre los de mayor nivel en la consecución de proyectos en convocatorias competitivas a nivel nacional. 7
  7. 7. 2 In dic ado res d e Prod ucc ión C ie n tífi ca
  8. 8. 2. Indicadores de Producción Científica Metodología Las publicaciones se presentan agrupadas por hospital / centro. Se ha seguido, como criterio para relacionar las publicaciones, el estar indexada en las bases de datos del Institute for Scientific Information (ISI), utilizándose un algoritmo de búsqueda y clasificación basado en criterios geográficos y de institución. Estas bases de datos están accesibles a través de la ISI's Web of Knowledge y permiten tener una relación de las citaciones de los artículos así como de su Factor de Impacto (FI). Dentro de cada hospital / centro, se han clasificado por el área temática en las que las incluye el propio ISI y se ha calculado el cuartil correspondiente a cada área temática utilizando el ranking de las revistas indexadas en ISI. Se han eliminado aquellas publicaciones que no aportan novedad científica relevante, como cartas al director, entre otras. Las duplicidades existentes en publicaciones pueden deberse a que se trate de: a. Una colaboración entre varios centros, por lo tanto aparece en varios centros b. Una publicación recogida en una revista clasificada en varias áreas temáticas ISI. En este caso, el factor de impacto es el mismo, pero los cuartiles pueden variar según el área temática. El valor acumulado del Factor de Impacto se calcula teniendo en cuenta estas duplicidades, de manera que no se incremente indebidamente. Se han considerado las autorías que identifican explícitamente al investigador en el campo autor de la base de datos y, por tanto, recogen filiación geográfica o institucional. Esto excluye las auditorias de grupo. Las publicaciones de los centros de atención primaria se han tratado en conjunto, de acuerdo a la estrategia del Programa Aragonés de Investigación en Atención Primaria (PAIAP). En cuanto a las publicaciones de la Universidad de Zaragoza, se han incluido las de aquellos investigadores incluidos en líneas coordinadas desde el Instituto, a través de la participación en convocatorias CIBER, RETICs, proyectos o grupos de investigación reconocidos por el Gobierno de Aragón. A continuación se muestran los principales indicadores de producción científica en 2010. 9
  9. 9. Tabla 1.1. Indicadores de producción científica Indicador Cálculo Resultado 231/354 0,65 1.383,884 1.383,884 Factor Impacto total / Nº total proyectos públicos 1.383,884/109 12,69 FI Total / Nº IPs 1.383,884/84 16,47 5.083.533 /1.383,884 3.673,38€ 7.199.873,80/393 18.320,29€ 7.199.873,80/1.383,884 5.202,66€ 7.199.873,80 /84 85.712,78€ Nº de artículos en revistas de 1er y 2º cuartil / Total artículos con FI Factor Impacto total Financiación pública proyectos activos / FI Total Coste por artículo según el total de ingresos (Total Ingresos proyectos / Nº Artículos) Coste por artículo según FI (Ingresos proyectos/ Factor impacto) Ingresos totales proyectos / Nº Investigadores Principales Tabla 1.2. Publicaciones por cuartiles y Factor Impacto Cuartil Nº Publicaciones Factor de Impacto Cuartil 1 136 1022,009 Cuartil 2 95 220,466 Cuartil 3 59 89,674 Cuartil 4 64 51,735 Sin Factor Impacto 39 - Total 393 1.383,884 En este año 2010 se han publicado 393 artículos (38% en primer cuartil) con un factor de impacto total de 1.383,884. De las 354 publicaciones con FI, 231 se posicionan en primer y segundo cuartil, lo que supone un 65%. 10
  10. 10. Figura 1.1: Publicaciones por cuartiles CUARTIL 4 18% CUARTIL 1 38% CUARTIL 3 17% CUARTIL 2 27% Figura 1.2: Factor de Impacto por Área Temática Respiratorio 67,034 Salud Mental 76,043 Regenerativa 59,16 Oncología 212,242 Medicina Interna 78,6 Cardiología 79,193 Hematología 86,132 Digestivo 166,84 Genética 143,211 Ingeniería Biomédica 122,382 11
  11. 11. Las áreas temáticas con un mayor factor de impacto son oncología, digestivo, genética e ingeniería biomédica seguidas de hematología, cardiología, medicina interna, salud mental, respiratorio y medicina regenerativa. A continuación, estos gráficos representan el número de publicaciones totales según área temática, así como las publicaciones de primer cuartil por área temática y su factor de impacto. Destaca el área de oncología con un alto factor de impacto, seguida de digestivo y genética. Figura 1.3: Publicaciones por Área Temática 250 200 150 100 50 O nc ol og ía Di ge In st ge G ivo ni e er ía n ét ic Bi om a éd He ica m at ol og Ca ía M ed rdio l ic in og í a a Sa In te rn lu a d M Re ent al sp Bi i oq Re r ato uí ri m ge ica ne o ra y Bi t Pe iva ol og ía diat ría m Ne olec u ur oc lar ie nc ia s Bi ol og ía Ci r O fta ugí a lm Sa ol og lu d í Pú a bl ica 0 Publicaciones FI Figura 1.4: Publicaciones de primer cuartil por Área Temática O nc ol og ía D ig es tiv o G M en ed ét ic ic in a a In te H rn In em a ge at ni ol er og ía í Bi om a éd Re ica ge ne ra S tiv al ud a M Bi en oq R ta es uí l pi m ra ica to y rio C B ar io di lo ol gí og a ía m ol ec ul ar Pe di at ría B io lo gí a C ir u Ne gí ur a oc ie nc ia s 200 180 160 140 120 100 80 60 40 20 0 Publicaciones FI 12
  12. 12. Figura 1.5: Factor de impacto por centro H Royo Villanova 35,003 Atención Primaria 20,665 Resto 32,98 H Barbastro 55,49 HCU Lozano Blesa 547,807 I+CS 129,847 H San Jorge 149,954 Universidad Zaragoza 393,164 H Miguel Servet 433,859 El Hospital Clínico Universitario Lozano Blesa, el Hospital Miguel Servet y la Universidad concentran el grueso del factor de impacto. En términos generales, el número de publicaciones por centro, así como su factor de impacto ha aumentado de manera exponencial con respecto al año anterior. Cabe destacar el importante incremento de este factor de impacto en el Hospital de San Jorge, del Hospital de Barbastro, así como de los investigadores adscritos a I+CS en comparación con el año 2009. Figura 1.6: Publicaciones por centro H Obispo Polanco 6 H Royo Villanova 14 H Calatayud 6 Resto 10 HCU Lozano Blesa 129 H San Jorge 21 I+CS 24 Universidad de Zaragoza 126 HU Miguel Servet 126 13
  13. 13. 3 Re lac ió n de ar tícu los 14
  14. 14. 3. Relación de artículos Atención Primaria FI: 20,665 A continuación se relacionan los artículos con factor de impacto, clasificados según área temática en los que algún autor procede de centros de Atención Primaria. 3.1.1 Atención Primaria Bellon JA;Luna JD;Moreno B;Monton-Franco C;GildeGomez-Barragan MJ;Sanchez-Celaya M;az-Barreiros MA;Vicens C;Motrico E;Martinez-Canavate MT;Olivan-Blazquez B;Vazquez-Medrano A;Sanchez-Artiaga MS;March S;Munoz-Garcia MD;Moreno-Peral P;Nazareth I;King M;Torres-Gonzalez F. Psychosocial and sociodemographic predictors of attrition in a longitudinal study of major depression in primary care: the predictD-Spain study.JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2010; 64(10):874-884. de Pedro-Cuesta J;Comin MC;Virues-Ortega J;Isla JA;Avellanal F;Cabero EA;Burzaco O;Castellote JM;Cieza A;Damian J;Forjaz MJ;Frades B;Franco E;Larrosa LA;Magallon R;Garcia GM;Martinez C;Martin PM;Pastor-Barriuso R;Jimenez AP;Martinez AP;Reed G;Ruiz C;.ICF-Based Disability Survey in a Rural Population of Adults and Older Adults Living in Cinco Villas, Northeastern Spain:Design, Methods and Population Characteristics. Neuroepidemiology 2010; 35:72-82. Fayed N;Garcia-Campayo J;Magallon R;Andres-Bergareche H;Luciano JV;Andres E;Beltran J;.Localized H-1-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and Nacetylaspartate.Arthritis research & Therapy 2010; 12(4). Perez-Palomares S;Olivan-Blazquez B;Magallon-Botaya R;De-la-Torre-Beldarrain M;Gaspar-Calvo E;Romo-Calvo L;GarciaLazaro R;Serrano-Aparicio B;.Percutaneous Electrical Nerve Stimulation Versus Dry Needling: Effectiveness in the Treatment of Chronic Low Back pain. Journal of musculoskeletal pain. 2010;18 (1): 23-30 Rodero B;Casanueva B;Garcia-Campayo J;Roca M;Magallon R;del Hoyo YL;.Stages of chronicity in fibromyalgia and pain catastrophising: a cross-sectional study.Bmc Musculoskel Dis.2010;11 3.1.2 Cardiovascular Leiva A;Fajo M;Escriche L;Audera FJ;Lopez S;Martin MC;Gonzalez R;Tamborero G;Garcia EM;Duro R;Orueta R;Serra F;D'agosto PP;Miralles J;Lorente P;Llobera J;Iglesias AA;Fernandez R;Colom MM;Buades AM;Moreno L;Vidal C;.Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial.Bmc Cardiovascular Dis.2010;44(10). 3.1.3 Geriatría y Gerontología Martin-Carrasco M;Otermin P;Perez-Camo V;Pujol J;Aguera L;Martin MJ;Gobartt AL;Pons S;Balana M;.EDUCA study: Psychometric properties of the Spanish version of the Zarit Caregiver Burden Scale.Aging Ment Health.2010;14(6):705-711 3.1.4 Medicina Interna Aznar TL;Pueyo FJO;Ciria SB;Torrente MR;Aisa BS;Baratech ACG;.Diagnostic yield of cognitive tests applied in primary care. Consistency and validity of screening tests.Aten Prim.2010;42(4):226-232 Cordoba-Garcia R;San Andres CS;.Three years of the smoking prevention law in Spain: The good and bad aspects.Aten Prim.2010;42(2):63-65 Garcia RC;Andres CS;Bonel PS;.Occupational passive smoker. When will there be a new anti-smoking law?.Aten Prim.2010;42(5):255-256 3.1.5 Oncología Fernandez SP;Diaz SP;Calvino BL;Santamaria PG;Pillado TS;Monreal FA;Macia F;Calavera MAS;Macias AE;Ayerbes MV;Pazos A;Lopez MR;Saez LG;Montserrat MR;Noguera JMS;Aliaga IM;Lujan LG;Rabadan MM;Nascimento CM;Pueyo O;Watts 15
  15. 15. MMB;Irigoyen EC;Abella MC;Pinilla M;Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol. 2010;10 3.1.6 Pediatría Casas AA;Martinez GR;Villagrasa MPS;Fernandez-Espinar JF;Cosculluela PB;Hernandez MPC;Bonel MFS;Galindo ABS;Martinez CP;.Differences Between Reference Charts of Weight in Children Up to the Age of 18 Months.Nutr Hosp.2010;25(5):838-844 3.1.7 Salud Mental Fayed N;Garcia-Campayo J;Magallon R;Andres-Bergareche H;Luciano JV;Andres E;Beltran J;.Localized H-1-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and Nacetylaspartate.Arthritis research & Therapy 2010; 12(4) Martin-Carrasco M;Otermin P;Perez-Camo V;Pujol J;Aguera L;Martin MJ;Gobartt AL;Pons S;Balana M;.EDUCA study: Psychometric properties of the Spanish version of the Zarit Caregiver Burden Scale.Aging Ment Health.2010;14(6):705-711 Rodero B;Casanueva B;Garcia-Campayo J;Roca M;Magallon R;del Hoyo YL;.Stages of chronicity in fibromyalgia and pain catastrophising: a cross-sectional study.Bmc Musculoskel Dis.2010;11 3.1.8 Salud Pública y Servicios Sanitarios Aibar MA;Laborda K;Conget F;Cornudella R;.Hypercoagulability state and endotelial injury in stable chronic obstructive pulmonary disease patients.An Sist Sanit Navar.2010;33(1):43-50 Garcia-Ortiz L;Recio-Rodriguez JI;Martin-Cantera C;Cabrejas-Sanchez A;Gomez-Arranz A;Gonzalez-Viejo N;Nicolas EIS;PatinoAlonso MC;Gomez-Marcos MA;.Physical exercise, fitness and dietary pattern and their relationship with circadian blood pressure pattern, augmentation index and endothelial dysfunction biological markers: EVIDENT study protocol. 2010;10 Martinez RG;Ibanez AM;Gomez PC;Villanueva ACG;Bergareche IA;Jaime CG;.Abdominal Girth Utility as a Method of Metabolic Syndrome Screening in People with Hypertension.Revista Espanola De Salud Publica.2010;84(2):215-222 Navarro RG;.Use of the FRAX Algorithm to Calculate the Fracture Risk in Women of a Rural Area.Revista Espanola De Salud Publica.2010;84(3):321-330 Hospital de Alcañiz FI: 2,958 A continuación se relacionan los artículos con factor de impacto, clasificados según área temática en los que algún autor procede del Hospital de Alcañiz 3.1.9 Medicina Interna Roa L;Monreal M;Carmona JA;Aguilar E;Coll R;Suarez C;.Treatment inertia in secondary prevention of cardiovascular disease. FRENA registry.Med Clin-barcelona.2010;134(2):57-63 Hospital de Barbastro FI: 55,49 A continuación se relacionan los artículos con factor de impacto, clasificados según área temática en los que algún autor procede del Hospital de Barbastro 3.1.10 Cardiovascular Leiva A;Fajo M;Escriche L;Audera FJ;Lopez S;Martin MC;Gonzalez R;Tamborero G;Garcia EM;Duro R;Orueta R;Serra F;D'agosto PP;Miralles J;Lorente P;Llobera J;Iglesias AA;Fernandez R;Colom MM;Buades AM;Moreno L;Vidal C;.Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial. BMC Cardiovascular disorders. 2010;10 16
  16. 16. 3.1.11 Neurociencias Gracia-Naya M;Huerta-Villanuev M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;rtal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients. Rev neurol. 2010;50 (9). 513-519 Modrego PJ;Fayed N;Errea JM;Rios C;Pina MA;Sarasa M;.Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.Eur J Neurol.2010;17(3):405-412 3.1.12 Oncología Martin M;Rodriguez-Lescure A;Ruiz A;Alba E;Calvo L;Ruiz-Borrego M;Santaballa A;Rodriguez CA;Crespo C;Abad M;Dominguez S;Florian J;Llorca C;Mendez M;Godes M;Cubedo R;Murias A;Batista N;Garcia MJ;Caballero R;de Alava E;.Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer. Breast cancer research and treatment.2010;123 (1):149-157 Martin M;Segui MA;Anton A;Ruiz A;Ramos M;Adrover E;Aranda I;Rodriguez-Lescure A;Grosse R;Calvo L;Barnadas A;Isla D;del Prado PM;Borrego M;Zaluski J;Arcusa A;Munoz M;Vega JM;Mel JR;Munarriz B;Llorca C;Jara C;Alba E;Florian J;Li JF;GarciaAsenjo JA;Saez A;Rios M, Almenar S, Peiro G, Lluch A;. Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer. New England Journal of Medicine. 2010;363 (23):2200-2210 Hospital de Calatayud FI: 12,61 A continuación se relacionan los artículos con factor de impacto, clasificados según área temática en los que algún autor procede del Hospital de Calatayud 3.1.13 Neurociencias Gracia-Naya M;Huerta-Villanueva M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;Artal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients. Rev neurol. 2010;50 (9). 513-519 3.1.14 Oncología Roca JM;Alonso V;Pericay C;Escudero P;Salud A;Losa F;Lopez LJ;Guasch I;Mendez M;Quintero-Aldana G;Grande C;Vicente P;Arrivi A;Martin C;Moreno I;Garcia P;Anton I;Constenla M;Yubero A;Cirera L;.Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer.Chemotherapy.2010;56(2):142-146 3.1.15 Pediatría Rodriguez G;Gallego S;Breidenassel C;Moreno LA;Gottrand F;.Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?.Nutr Hosp.2010;25(5):712-717 3.1.16 Respiratorio Dominguez A;Izquierdo C;Salleras L;Ruiz L;Sousa D;Bayas JM;Nebot M;Varona W;Celorrio JM;Carratala J;.Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly.Eur Respir J.2010;36(3):608-614 3.1.17 Salud Pública Izquierdo C;Oviedo M;Ruiz L;Sintes X;Vera I;Nebot M;Bayas JM;Carratala J;Varona W;Sousa D;Celorrio JM;Salleras L;Dominguez A;.Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study. BMC Public Health. 2010;10 17
  17. 17. 3.1.18 Arnal Urología y Nefrología LML;Gutierrez AS;.Prevalence of BC;Izquierdo chronic kidney MC;Garcia OG;Alcaine disease in patients JMT;Garcia SB;Orna with 2 type JAG;Juliani diabetes mellitus BB;Hernandez-French treated in primary care.Nefrologia.2010;30(5):552-556 Hospital Clínico Universitario Lozano Blesa FI: 547,807 A continuación se relacionan los artículos con factor de impacto, clasificados según área temática en los que algún autor procede del Hospital Clínico Universitario Lozano Blesa 3.1.19 Alergología Elfau MTS;Sotillos MG;Claveria LF;Arazuri NS;Ballarin SM;Sanz CC;.Study of Cross-Reactivity Between Proton Pump Inhibitors.J Invest Allerg Clin.2010;20(2):157-161 3.1.20 Biología Perez-Lopez FR;Larrad-Mur L;Kallen A;Chedraui P;Taylor HS;.Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences.Reprod Sci.2010;17(6):511-531 3.1.21 Bioquímica y biología molecular Perez-Lopez FR;Chedraui P;Cuadros-Lopez JL;.Bone Mass Gain During Puberty and Adolescence: Deconstructing Gender Characteristics.Curr Med Chem.2010;17(5):453-466 3.1.22 Biotecnología Arias A;Seral C;Gude MJ;Castillo FJ;.Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria.Int Microbiol.2010;13(3):135-141 3.1.23 Cardiovascular Cabrerizo García JL, Zalba Etayo B, Pérez Calvo JI. .Prognostic value of occult renal failure in the acute coronary syndrome.Rev Clin Esp.2010;210(4):204-201 Garcia JLC;Etayo BZ;Calvo JIP;.Prognostic value of glomerular filtrate in acute coronary syndrome: Cockcroft's index or MDRD equation?.Med Clin-barcelona.2010;134(14):624-629 Murillo EC;Saez FD;Ruiz APA;Zorita JF;Alcantara AG;Aguado GH;Messa JBL;Rodriguez JAM;.The recommendations regarding non-ST segment elevation acute coronary syndrome have been reviewed.Medicina Intensiva.2010;34(1):22-45 Olivera S;Amores B;Torralba MA;Calvo JIP;.Rare complication in a patient with giant cell arteritis.An Sist Sanit Navar.2010;33(3):327-330 Perez Calvo JI;Fernandez de la Puebla Gimenez;.Neurologic involvement in type 1 Gaucher's disease.Med Clinbarcelona.2010;134(11):489-491 Ruiz FJR;Abad DS;Bergua BS;.Therapeutic alternatives for treating heart failure in elderly patients.Salud I Ciencia.2010;17(5):428-431 Sanchez-Marteles M;Medina AM;Saiz EB;Laiglesia FR;Rodriguez JAN;Perez-Calvo JI;.Prognostic value of NT-proBNP in chronic pulmonary disease exacerbation.Med Clin-barcelona.2010;135(10):441-446 3.1.24 Cirugía Cristobal JA;Remon L;Del Buey MA;Montes-Mico R;.Multifocal intraocular lenses for unilateral cataract in children.J Cataract Refr Surg.2010;36(12):2035-2040 18
  18. 18. Garcia-Gil FA;Lampreave F;Fuentes-Broto L;Carpintero R;Gonzalvo E;Garcia JJ;varez-Alegret R;Alfaro J;Orden I;Roda L;.Interalpha-trypsin inhibitor heavy chain 4 as a marker of acute rejection in pancreas allotransplantation in pigs.Transpl P.2010;42(8):30 Lamata P;Lamata F;Sojar V;Makowski P;Massoptier L;Casciaro S;Ali W;Studeli T;Declerck J;Elle OJ;Edwin B;.Use of the Resection Map system as guidance during hepatectomy.Surg Endosc.2010;24(9):2327-2337 Martinez-Lostao L;Garcia-Alvarez F;Basanez G;egre-Aguaron E;Desportes P;Larrad L;Naval J;Martinez-Lorenzo MJ;Anel A;.Liposome-Bound APO2L/TRAIL Is an Effective Treatment in a Rabbit Model of Rheumatoid Arthritis.Arthritis Rheumus.2010;62(8):2272-2282 Rodriguez-Galietero A;Martinez JVG;Del Buey A;Bescos JAC;.Use of Brimonidine Before LASIK With Femtosecond Lasercreated Flaps for the Correction of Myopia: A Contralateral Eye Study.J Refract Surg.2010;26(1):28-32 Serrano MT;Garcia-Gil A;Arenas J;Ber Y;Cortes L;Valiente C;Araiz JJ;.Outcome of liver transplantation using donors older than 60 year of age.Clin Transplant.2010;24(4):543-549 Valldeoriola F;Regidor I;Minguez-Castellanos A;Lezcano E;Garcia-Ruiz P;Rojo A;Salvador A;Castro A;Grandas F;Kulisevsky J;Marti MJ;Martinez-Martin P;Relova L;Rumia J;Camara A;Burguera JA;Linazasoro G;de Val JL;Obeso J;Rodriguez-Oroz MC;Tolosa E;.Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. Journal of neurology neurosurgery and psychiatry.2010;81(1):65-69 3.1.25 Dermatología Torrelo A;Fernandez-Crehuet P;Del Prado E;Martes P;Hernandez-Martin A;De Diego V;Carapeto F;.Extensive Comedonal and Cystic Acne in Patau Syndrome.Pediatr Dermatol.2010;27(2):199-200 3.1.26 Digestivo Abian O;Vega S;Neira JL;Velazquez-Campoy A;.Conformational Stability of Hepatitis C Virus NS3 Protease.Biophys J.2010;99(11):3811-3820 Abuli A;Bessa X;Gonzalez JR;Ruiz-Ponte C;Caceres A;Munoz J;Gonzalo V;Balaguer F;Fernandez-Rozadilla C;Gonzalez D;de Castro L;Clofent J;Bujanda L;Cubiella J;Rene JM;Morillas JD;Lanas A;Rigau J;Garcia AM;Latorre M;Salo J;Banares FF;Arguello L;Pena E;Vilella A.Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer Phenotype.Gastroenterology.2010;139(3):788-U129 Bhatt DL;Cryer BL;Contant CF;Cohen M;Lanas A;Schnitzer TJ;Shook TL;Lapuerta P;Goldsmith MA;Laine L;Scirica BM;Murphy SA;Cannon CP;.Clopidogrel with or without Omeprazole in Coronary Artery Disease.New Engl J Med.2010;363(20):1909-1917 Borras E;Pineda M;Blanco I;Jewett EM;Wang F;Teule A;Caldes T;Urioste M;Martinez-Bouzas C;Brunet J;Balmana J;Torres A;Cajal TRY;Sanz J;Perez-Cabornero L;Castellvi-Bel S;Alonso A;Lanas A;Gonzalez S;Moreno V;Gruber SB;Rosenberg NA;Mukherjee B;Lazaro C;Capella G. MLH1 Founder Mutations with Moderate Penetrance in Spanish Lynch Syndrome Families. Cancer Research.2010;70(19):7379-7391 Burmester G;Lanas A;Biasucci L;Hermann M;Lohmander S;Olivieri I;Scarpignato C;Smolen J;Stoevelaar H;.The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel.Ann Rheum Dis.201 Casado-Arroyo R;Scheiman JM;Polo-Tomas M;Saini SD;del Rio A;Guastello E;Lanas A;.Underutilization of gastroprotection for at-risk patients undergoing percutaneous coronary intervention: Spain compared with the United States.Aliment Pharm Ther.2010;32(5):6 Chan FKL;Lanas A;Scheiman J;Berger MF;Nguyen H;Goldstein JL;.Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.Lancet.2010;376(9736):173-179 Chan FKL;Cryer B;Goldstein JL;Lanas A;Peura DA;Scheiman JM;Simon LS;Singh G;Stillman MJ;Wilcox CM;Berger MF;Breazna A;Dodge W;.A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract. Journal of rheumatology.2010;37(1):167-174 19
  19. 19. Dignass A;Van Assche G;Lindsay JO;Lemann M;Soderholm J;Colombel JF;Danese S;D'Hoore A;Gassull M;Gomollon F;Hommes DW;Michetti P;O'Morain C;Oresland T;Windsor A;Stange EF;Travis SPL;.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.Journal of Crohns & colitis.2010;4(1):28-62 Domenech R;Abian O;Bocanegra R;Correa J;Sousa-Herves A;Riguera R;Mateu MG;Fernandez-Megia E;Velazquez-Campoy A;Neira JL;.Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV- 1.Biomacromolecules.2010;11(8):2069-2078 Ferrandez A;Navarro M;Diez M;Sopena F;Roncales P;Polo-Tomas M;Sainz R;Lanas A;.Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation.Endoscopy.2010;42(12):1071-1076 Gisbert JP;Gomollon F;Hinojosa J;San Roman AL;.Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: A real-life survey in Spain.J Crohns Colitis.2010;4(5):567-574 Gomollon F;Gisbert JP;.Must immunomodulators be added to biological treatment in inflammatory bowel disease?.Gastroenterologia Y Hepatologia.2010;33(1):43-53 Jimenez P;Piazuelo E;Cebrian C;Ortego J;Strunk M;Garcia-Gonzalez MA;Santander S;Alcedo J;Lanas A;.Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.Aliment Pharm Ther.2010;31(3):440451 Ladabaum U;Ferrandez A;Lanas A;.Cost-Effectiveness of Colorectal Cancer Screening in High-Risk Spanish Patients: Use of a Validated Model to Inform Public Policy.Cancer Epidem Biomar.2010;19(11):2765-2776 Lanas A;.A review of the gastrointestinal safety data-a gastroenterologist's perspective.Rheumatology.2010;49:ii3-ii10 Lanas A;.Proton pump inhibitors and clopidogrel in a patient with cardiovascular risk factors: Cardiovascular versus gastrointestinal risk?.Gastroenterol Hepatol.2010;33(1):1-5 Lanas A;Calvet X;Feu F;Ponce J;Gisbert JP;Barkun A;.First Spanish consensus on peptic ulcer bleeding management.Med Clinbarcelona.2010;135(13):608-616 Lanas A;Letelier C;Caamano E;Massardo T;Gonzalez P;Araya AV;.Frequency of positive anti thyroid peroxidase antibody titers among normal individuals.Rev Med Chile.2010;138(1):15-21 Lanas A;Munoz M;Correa MC;Jimenez PM;.Analysis of differences between indication and prescription of gastroprotection inpatients with risk factors treated with nonsteroidal anti-inflammatory agents: The GAP study.Gastroenterologia Y Hepatologia.2010;33(2) Lanas A;Tornero J;Zamorano JL;.Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study.Ann Rheum Dis.2010;69(8):1453-1458 Lopera JE;De Gregorio MA;.Fluoroscopic management of complications after colorectal stent placement.Gut Liver.2010;4(SUPPL. 1):S9-S18 Mearin F;Balboa A;Castells A;Dominguez JE;Esteve M;Garcia-Erce JA;Gisbert JP;Gomollon F;Panes J;Ponce J;.Iron deficiency anemia and use of intravenous iron in digestive disease.Gastroenterologia Y Hepatologia.2010;33(8):605-613 Olivera-Gonzalez S;de Escalante-Yanguela B;Velilla-Soriano C;mores-Arriaga B;Martin-Fortea P;Navarro-Aguilar ME;.Metforminassociated hepatotoxicity.Medicina Intensiva.2010;34(7):483-487 Sostres C;Gargallo CJ;Arroyo MT;Lanas A;.Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.Best Pract Res Cl Ga.2010;24(2):121-132 Uribarrena-Amezaga R;Ortego J;Fuentes J;Raventos N;Parra P;Uribarrena-Echevarria R;.Prognostic value of lymph node micrometastases in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0).Rev Esp Enferm Dig.2010;102(3):176-181 yuso-Tejedor S;Angarica VE;Bueno M;Campos LA;Abián O;Bernadó P;Sancho J;Jiménez MA;.Design and structure of an equilibrium protein folding intermediate: a hint into dynamical regions of proteins.J Mol Biol.2010;400(4):922-934 20
  20. 20. 3.1.27 Endocrinología y Metabolismo Chedraui P;Perez-Lopez FR;Blumel JE;Hidalgo L;Barriga J;.Hyperglycemia. in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints.Gynecol Endocrinol.2010;26(2):86-92 de los Terreros AS;Aguillo E;Faure E;Domene R;Ibanez J;Garijo C;.Reliability of Stereoscopic Nonmydriatic Retinography for Assessment of Diabetic Macular Edema when Performed by Endocrinologists.Diabetes Technol The.2010;12(3):179-183 Perez-Lopez FR;Cuadros-Lopez JL;Fernandez-Alonso AM;Cuadros-Celorrio AM;Sabatel-Lopez RM;Chedraui P;.Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens.Ginecological endocrinology.2010;26(7):533-538 3.1.28 Enfermedades infecciosas Arias A;Seral C;Navarro F;Miro E;Coll P;Castillo FJ;.Plasmid-mediated QnrS2 determinant in an Aeromonas caviae isolate recovered from a patient with diarrhoea.Clin Microbiol Infec.2010;16(7):1005-1007 Goni P;Aldana DE;Clavel A;Seral C;Remacha MA;Castillo FJ;.Prevalence of Giardia duodenalis assemblage B in humans in Zaragoza and Leon, Spain.Enferm Infec Micr Cl.2010;28(10):710-712 Martin-Fortea MP;Aibar MA;de Escalante B;Olivera S;Letona S;Vitoria MA;Echezarreta C;.Peritoneal tuberculosis: a 16-year review in a general hospital.Enferm Infec Micr Cl.2010;28(3):162-168 Olaechea PM;Insausti J;Blanco A;Luque P;.Epidemiology and impact of nosocomial infections.Medicina Intensiva.2010;34(4):256267 Trevino A;Garcia J;de Mendoza C;Benito R;Aguilera A;de Lejarazu RO;Ramos JM;Trigo M;Eiros JM;Rodriguez-Iglesias M;Torres A;Calderon E;Hernandez A;Gomez C;Marcaida G;Soriano V;.Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey.AIDS research and human retroviruses.2010;26(8):861-864 3.1.29 Farmacología & Farmacia Perez-Lopez FR;Chedraui P;Cuadros-Lopez JL;.Bone Mass Gain During Puberty and Adolescence: Deconstructing Gender Characteristics.Curr Med Chem.2010;17(5):453-466 3.1.30 Genética Gaudet MM;Kirchhoff T;Green T;Vijai J;Korn JM;Guiducci C;Segre AV;Mcgee K;McGuffog L;Kartsonaki C;Morrison J;Healey S;Sinilnikova OM;Stoppa-Lyonnet D;Mazoyer S;Gauthier-Villars M;Sobol H;Longy M;Frenay M;Hogervorst FBL;Rookus MA;Collee JM;Hoogerbrugge N;Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer.Plos Genetics.2010;6(10):e1001183 Rohatgi S;Clark D;Kline AD;Jackson LG;Pie J;Siu V;Ramos FJ;Krantz ID;Deardorff MA;.Facial Diagnosis of Mild and Variant CdLS: Insights From a Dysmorphologist Survey.Am J Med Genet A.2010;152A(7):1641-1653 3.1.31 Geriatría y Gerontología Chedraui P;Perez-Lopez FR;Mendoza M;Leimberg ML;Martinez MA;Vallarino V;Hidalgo L;.Assessment of self-esteem in midaged women.Maturitas.2010;66(1):77-82 Chedraui P;Perez-Lopez FR;Mendoza M;Leimberg ML;Martinez MA;Vallarino V;Hidalgo L;.Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth Sleepiness Scale.Maturitas.2010;65(1):75-80 3.1.32 Hematología Azaceta G, Calasanz MJ, Dourdil V, Bonafonte E, Izquierdo I, Palomera L..Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation..Leuk Lymphoma.2010;51(10):1941-1943 de la Rubia J, Roig M, Ibáñez A, García I, Vera JA, Aguilar C, del Campo R, González N, Martínez R, Palomera L, Picón I, Rodríguez JN, Sanz MA..Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.European Journal Haematology.2010;85(4):363-365 21
  21. 21. Mateos MV;Oriol A;Martinez-Lopez J;Gutierrez N;Teruel AI;de Paz R;Garcia-Larana J;Bengoechea E;Martin A;Mediavilla JD;Palomera L;de Arriba F;Gonzalez Y;Hernandez JM;Sureda A;Bello JL;Bargay J;Penalver FJ;Ribera JM;Martin-Mateos ML;Garcia-Sanz R;Cibeira MT.Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial. Lancet Oncology.2010;11(10):934-941 Otero R;Uresandi F;Jimenez D;Cabezudo MA;Oribe M;Nauffal D;Conget F;Rodriguez C;Cayuela A;.Home treatment in pulmonary embolism.Thromb Res.2010;126(1):E1-E5 3.1.33 Ingeniería Biomédica Mellado X;Cruz S;Artacho JM;Canellas M;.Reducing the number of segments in unidirectional MLC segmentations.Phys Med Biol.2010;55(3):N75-N85 3.1.34 Inmunología Elfau MTS;Sotillos MG;Claveria LF;Arazuri NS;Ballarin SM;Sanz CC;.Study of Cross-Reactivity Between Proton Pump Inhibitors.J Invest Allerg Clin.2010;20(2):157-161 Garcia-Gil FA;Lampreave F;Fuentes-Broto L;Carpintero R;Gonzalvo E;Garcia JJ;varez-Alegret R;Alfaro J;Orden I;Roda L;.Interalpha-trypsin inhibitor heavy chain 4 as a marker of acute rejection in pancreas allotransplantation in pigs.Transpl P.2010;42(8):30 Trevino A;Garcia J;de Mendoza C;Benito R;Aguilera A;de Lejarazu RO;Ramos JM;Trigo M;Eiros JM;Rodriguez-Iglesias M;Torres A;Calderon E;Hernandez A;Gomez C;Marcaida G;Soriano V;.Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey.AIDS research and human retroviruses.2010;26(8):861-864 3.1.35 Medicina Interna Alfaro I;Ocana T;Castells A;Cordero C;Ponce M;Cajal TRY;Andreu M;Bujanda L;Herraiz M;Molina AJH;Fernandez-Banares F;Riestra-Menendez S;Gargallo C;Ruiz A;Bustamante M;Blanco I;de Juan FM;.Characteristics of patients with familial adenomatous polyposis in Spain. First results of the Spanish Registry of Familial Adenomatous Polyposis.Medicina Clínica.2010;135(3):103-108 Cabrerizo JL;Zalba B;Perez JI;Ruiz F;.Leukocyte count as a risk factor for coronary adverse events among patients admitted for an acute coronary syndrome.Rev Med Chile.2010;138(3):274-280 Duenas-Laita A;Putze GB;Alonso JR;Bajo A;Climent B;Corral E;Felices F;Ferrer A;Frutos MPH;Nogue S;Puiguriguer J;.Basis for the clinical management of fire smoke poisoning 'Docohumo Madrid 2010'.Medicina Intensiva.2010;34(9):609-619 Duenas-Laita A;Putze GB;Alonso JR;Bajo A;Climent B;Corral E;Felices F;Ferrer A;Frutos MDH;Nogue S;Puiguriguer J;.Fundamentals in the clinical management of intoxication due to smoke inhalation.Emergencias.2010;22(5):384-394 Mendoza MA;Ruiz FJM;Lasfuentes PC;Aznarez HN;Espanol AP;Hernandez MJR;.Tumour necrosis factor alpha antagonists in established rheumatoid arthritis: Effectiveness comparative study.Med Clin-barcelona.2010;134(15):665-670 3.1.36 Microbiología Arias A;Seral C;Gude MJ;Castillo FJ;.Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria.Int Microbiol.2010;13(3):135-141 Arias A;Seral C;Navarro F;Miro E;Coll P;Castillo FJ;.Plasmid-mediated QnrS2 determinant in an Aeromonas caviae isolate recovered from a patient with diarrhoea.Clin Microbiol Infec.2010;16(7):1005-1007 Goni P;Aldana DE;Clavel A;Seral C;Remacha MA;Castillo FJ;.Prevalence of Giardia duodenalis assemblage B in humans in Zaragoza and Leon, Spain.Enferm Infec Micr Cl.2010;28(10):710-712 Martin-Fortea MP;Aibar MA;de Escalante B;Olivera S;Letona S;Vitoria MA;Echezarreta C;.Peritoneal tuberculosis: a 16-year review in a general hospital.Enferm Infec Micr Cl.2010;28(3):162-168 22
  22. 22. 3.1.37 Neurociencias Gracia-Naya M;Huerta-Villanueva M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;rtal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients.Revista de Neurología.2010;50(9):513-519 Llerda JAM;Cerda JM;Corral JA;Errazquin FP;Quilo G;Jimenez PM;.Management of Patients With Unclassified Epileptic Seizures in Outpatient Clinics in Spain. Results of the RETO Study.Int J Neurosci.2010;120(11):711-716 Montanes-Rada F;Gastaminza-Perez X;Catala MA;Ruiz-Sanz F;Ruiz-Lazaro PM;Herreros-Rodriguez O;Garcia-Giral M;OrtizGuerra J;da-Diez JA;Mojarro-Praxedes D;Canto-Diez T;Mardomingo-Sanz MJ;Sasot-Llevadot J;Pamias M;Rey-Sanchez F;.GEITDAH consensus on attention deficit hyperactivity disorder.Revista de neurología.2010;51(10):633-637 Valldeoriola F;Regidor I;Minguez-Castellanos A;Lezcano E;Garcia-Ruiz P;Rojo A;Salvador A;Castro A;Grandas F;Kulisevsky J;Marti MJ;Martinez-Martin P;Relova L;Rumia J;Camara A;Burguera JA;Linazasoro G;de Val JL;Obeso J;Rodriguez-Oroz MC;Tolosa E;.Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study.Journal of neurology neurosurgery and psychiatry.2010;81(1):65-69 3.1.38 Nutrición y Dietética Ocon J;Garcia B;Benito P;Gimeno S;Garcia R;Lopez P;.Effect of Gastric Bypass on the Metabolic Syndrome and on Cardiovascular Risk.Nutr Hosp.2010;25(1):67-71 Vila MP;Hernandez JA;de Lorenzo AG;Perez SC;Sanz ML;Garcia-Lorda P;Brosa M;.The burden of hospital malnutrition in Spain: methods and development of the PREDyCES (R) study.Nutr Hosp.2010;25(6):1020-1024 3.1.39 Obstetricia y Ginecología Chedraui P;Perez-Lopez FR;Mendoza M;Leimberg ML;Martinez MA;Vallarino V;Hidalgo L;.Assessment of self-esteem in midaged women.Maturitas.2010;66(1):77-82 Chedraui P;Perez-Lopez FR;Mendoza M;Leimberg ML;Martinez MA;Vallarino V;Hidalgo L;.Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth Sleepiness Scale.Maturitas.2010;65(1):75-80 Chedraui P;Perez-Lopez FR;Blumel JE;Hidalgo L;Barriga J;.Hyperglycemia in postmenopausal women screened for the metabolic syndrome is associated to increased sexual complaints.Gynecol Endocrinol.2010;26(2):86-92 Chedraui P;Perez-Lopez FR;Mendoza M;Morales B;Martinez MA;Salinas AM;Hidalgo L;.Severe menopausal symptoms in middleaged women are associated to female and male factors.Arch Gynecol Obstet.2010;281(5):879-885 Perez-Lopez FR;Chedraui P;.Chagas disease in pregnancy: a non-endemic problem in a globalized world.Arch Gynecol Obstet.2010;282(6):595-599 Perez-Lopez FR;Cuadros-Lopez JL;Fernandez-Alonso AM;Cuadros-Celorrio AM;Sabatel-Lopez RM;Chedraui P;.Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens.Gynecological endocrinology.2010;26(7):533-538 Perez-Lopez FR;Larrad-Mur L;Kallen A;Chedraui P;Taylor HS;.Gender Differences in Cardiovascular Disease: Hormonal and Biochemical Influences.Reprod Sci.2010;17(6):511-531 3.1.40 Oftalmología Ascaso FJ;Cardenosa E;Cascante JM;Lario B;Perez D;Cristobal JA;.Acute postoperative endophthalmitis caused by Gemella morbillorum.Eur J Ophthalmol.2010;20(3):608-611 Ascaso FJ;Lopez-Gallardo E;Del Prado E;Ruiz-Pesini E;Montoya J;.Macular lesion resembling adult-onset vitelliform macular dystrophy in Kearns-Sayre syndrome with multiple mtDNA deletions.Clin Exp Ophthalmol.2010;38(8):812-816 Cristobal JA;Remon L;Del Buey MA;Montes-Mico R;.Multifocal intraocular lenses for unilateral cataract in children.J Cataract Refr Surg.2010;36(12):2035-2040 Garcia-Ayuso D;Salinas-Navarro M;Agudo M;Cuenca N;Pinilla I;Vidal-Sanz M;Villegas-Perez MP;.Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina.Exp Eye Res.2010;91(6):800-810 23
  23. 23. Rodriguez-Galietero A;Martinez JVG;Del Buey A;Bescos JAC;.Use of Brimonidine Before LASIK With Femtosecond Lasercreated Flaps for the Correction of Myopia: A Contralateral Eye Study.J Refract Surg.2010;26(1):28-32 3.1.41 Oncología Alvarez Lopez I;De La Haba Rodriguez J;Ruiz Simon A;Bellet Ezquerra M;Calvo Martinez L;Garcia Estevez L;Rodriguez Lescure A;Isla Casado D;.SEOM clinical guidelines for the treatment of metastatic breast cancer.Clin Transl Oncol.2010;12(11):719-723 Antoniou AC;Beesley J;McGuffog L;Sinilnikova OM;Healey S;Neuhausen SL;Ding YC;Rebbeck TR;Weitzel JN;Lynch HT;Isaacs C;Ganz PA;Tomlinson G;Olopade OI;Couch FJ;Wang XS;Lindor NM;Pankratz VS;Radice P;Manoukian S;Peissel B;Zaffaroni D;Barile M;Viel A;Allavena.Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction.Cancer Research.2010;70(23):9742-9754 Artal CA;Domine GM;Font PA;Garcia CR;Cobo DM;Isla CD;.SEOM clinical guidelines for the treatment of small-cell lung cancer.Clin Transl Oncol.2010;12(1):27-31 Borgonon MP;Nin RM;Hernandez JJC;Casado DI;.SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.Clin Transl Oncol.2010;12(11):749-752 Carcereny E;Ramirez JL;Sanchez-Ronco M;Isla D;Cobo M;Moran T;de Aguirre I;Okamoto T;Wei J;Provencio M;Lopez-Vivanco G;Camps C;Domine M;Alberola V;Sanchez JM;Massuti B;Mendez P;Taron M;Rosell R;.Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.Lung Cancer.2010;68(3):491-497 Castilla E;Pascual I;Roncales F;Aguirre E;Del RA;.Transient response of cardiac angiosarcoma to paclitaxel.Eur J Cancer Care.2010;19(5):699-700 Ciruelos EM;Cortes J;Cortes-Funes H;Mayordomo JI;Bermejo B;Ojeda B;Garcia E;Rodriguez CA;Munoz M;Gomez P;Manso L;Andres R;Lluch A;Saura C;Mendiola C;Baselga J;.Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).Annals of Oncology.2010;21(7):1442-1447 Codina JG;Dominguez PS;Pulla MP;Dominguez AR;Casado DI;.SEOM clinical guidelines for the treatment of diffuse large B-cell lymphoma.Clin Transl Oncol.2010;12(11):765-769 Del Barco Berron S;Ciruelos Gil E;Tusquets Trias De Bes I;Munoz Mateu M;Sanchez Rovira P;Rodriguez Lescure A;Isla Casado D;.SEOM clinical guidelines for the treatment of early breast cancer.Clin Transl Oncol.2010;12(11):711-718 Feliu J;Safont MJ;Salud A;Losa F;Garcia-Giron C;Bosch C;Escudero P;Lopez R;Madroal C;Bolaos M;Gil M;Llombart A;CastroCarpeo J;Gonzalez-Baron M;.Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.British Journal of cancer.2010;102(10):1468-1473 Felip E;Rosell R;Maestre JA;Rodriguez-Paniagua JM;Moran T;Astudillo J;Alonso G;Borro JM;Gonzalez-Larriba JL;Torres A;Camps C;Guijarro R;Isla D;Aguilo R;Alberola V;Padilla J;Sanchez-Palencia A;Sanchez JJ;Hermosilla E;Massuti B;.Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non-Small-Cell Lung Cancer.Journal of Clinical Oncology.2010;28(19):3138-3145 Fernandez-Martos C;Pericay C;Aparicio J;Salud A;Safont M;Massuti B;Vera R;Escudero P;Maurel J;Marcuello E;Mengual JL;Saigi E;Estevan R;Mira M;Polo S;Hernandez A;Gallen M;Arias F;Serra J;Alonso V;.Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study.Journal of clinical oncology.2010;28(5):859-865 Garcia Gomez J;Perez Lopez ME;Garcia Mata J;Isla Casado D;.SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.Clin Transl Oncol.2010;12(11):770-774 Gravalos Castro C;Maurel Santasusana J;Rivera Herrero F;Salazar Soler R;Sevilla Garcia I;Sastre Valera J;Tabernero Caturla JM;Gonzalez Flores E;Lomas Garrido M;Isla Casado D;.SEOM clinical guidelines for the adjuvant treatment of colorectal cancer.Clin & Translational Oncology.2010;12(11):724-728 Losada MJV;Monterde VB;Arriaga BA;Perez AIF;Solares SS;Puyal MM;.Lung carcinosarcoma.Clin Transl Oncol.2010;12(4):303305 24
  24. 24. Martin-Broto J;Gutierrez A;Garcia-del-Muro X;Lopez-Guerrero JA;Martinez-Trufero J;de Sande LM;Lainez N;Maurel J;De Juan A;Losa F;Andres R;Casado A;Tejido PG;Blanco R;Carles J;Bellmunt J;Gomez-Espana A;Ramos R;Martinez-Serra J;LlombartBosch A;Poveda A;.Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.Annals of oncology.2010;21(7):1552-1557 Martin M;Segui MA;Anton A;Ruiz A;Ramos M;Adrover E;Aranda I;Rodriguez-Lescure A;Grosse R;Calvo L;Barnadas A;Isla D;del Prado PM;Borrego M;Zaluski J;Arcusa A;Munoz M;Vega JM;Mel JR;Munarriz B;Llorca C;Jara C;Alba E;Florian J;Li JF;GarciaAsenjo JA;Saez A. Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.New England Journal of Medicine.2010;363(23):2200-2210 Martinez-Trufero J;Isla D;Adansa JC;Irigoyen A;Hitt R;Gil-Arnaiz I;Lambea J;Lecumberri MJ;Cruz JJ;.Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.British Journal of Cancer.2010;102(12):1687-1691 Mesia Nin R;Pastor Borgonon M;Cruz Hernandez JJ;Isla Casado D;.SEOM clinical guidelines for the treatment of head and neck cancer.Clin Transl Oncol.2010;12(11):742-748 Moros MT;Ruidiaz M;Caballero A;Serrano E;Martinez V;Tres A;.Effects of an exercise training program on the quality of life of women with breast cancer on chemotherapy.Rev Med Chile.2010;138(6):715-722 Roca JM;Alonso V;Pericay C;Escudero P;Salud A;Losa F;Lopez LJ;Guasch I;Mendez M;Quintero-Aldana G;Grande C;Vicente P;Arrivi A;Martin C;Moreno I;Garcia P;Anton I;Constenla M;Yubero A;Cirera L;.Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer.Chemotherapy.2010;56(2):142-146 Rodriguez-Abreu D;Llanos Munoz M;Provencio Pulla M;Rueda Dominguez A;Isla Casado D;.SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.Clin Transl Oncol.2010;12(11):760-764 Trigo Perez JM;Garrido Lopez P;Felip Font E;Isla Casado D;.SEOM clinical guidelines for the treatment of non-small-cell lung cancer: An updated edition.Clin Transl Oncol.2010;12(11):735-741 Truong T;Hung RJ;Amos CI;Wu XF;Bickeboller H;Rosenberger A;Sauter W;Illig T;Wichmann HE;Risch A;Dienemann H;Kaaks R;Yang P;Jiang RX;Wiencke JK;Wrensch M;Hansen H;Kelsey KT;Matsuo K;Tajima K;Schwartz AG;Wenzlaff A;Seow A;Ying C;Staratschek-Jox A;Nurnberg P.Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer Consortium.Journal of the National Cancer Institute.2010;102(13):959-971 Quero Blanco C;Garcia Arroyo R;Provencio Pulla M;Rueda Dominguez A;Isla Casado D;.SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.Clin Transl Oncol.2010;12(11):753-759 3.1.42 Pediatría Artero EG;Ortega FB;Espana-Romero V;Labayen I;Huybrechts I;Papadaki A;Rodriguez G;Mauro B;Widhalm K;Kersting M;Manios Y;Molnar D;Moreno LA;Sjostrom M;Gottrand F;Castillo MJ;De Henauw S;.Longer Breastfeeding Is Associated with Increased Lower Body Explosive Strength during Adolescence.Journal of Nutrition.2010;140(11):1989-1995 Casas AA;Martinez GR;Villagrasa MPS;Fernandez-Espinar JF;Cosculluela PB;Hernandez MPC;Bonel MFS;Galindo ABS;Martinez CP;.Differences Between Reference Charts of Weight in Children Up to the Age of 18 Months.Nutr Hosp.2010;25(5):838-844 Moreno LA;Rodriguez G;Fleta J;Bueno-Lozano M;Lazaro A;Bueno G;.Trends of dietary habits in adolescents.Crit Rev Food Sci.2010;50(2):106-112 Perez-Lopez FR;Chedraui P;Cuadros-Lopez JL;.Bone Mass Gain During Puberty and Adolescence: Deconstructing Gender Characteristics.Curr Med Chem.2010;17(5):453-466 Rodriguez G;Gallego S;Breidenassel C;Moreno LA;Gottrand F;.Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?.Nutr Hosp.2010;25(5):712-717 Torrelo A;Fernandez-Crehuet P;Del Prado E;Martes P;Hernandez-Martin A;De Diego V;Carapeto F;.Extensive Comedonal and Cystic Acne in Patau Syndrome.Pediatr Dermatol.2010;27(2):199-200 25
  25. 25. 3.1.43 Radiología, Medicina Nuclear y Diagnóstico por imagen Andres A;Tardin L;Santapau A;Razola P;Prats E;Parra A;Rivas MA;Ruiz P;Alvarez R;Camara A;Banzo J;.Treatment with I-131 of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure.Rev Esp Med Nucl.2010;29(1):32-35 Banzo J;Ubieto MA;Prats E;Razola P;Tardin L;Andres A;Santapau A;Parra A;.F-18-FDG PET-CT in cytomegalovirus-induced mononucleosis.Rev Esp Med Nucl.2010;29(6):304-307 Mellado X;Cruz S;Artacho JM;Canellas M;.Reducing the number of segments in unidirectional MLC segmentations.Phys Med Biol.2010;55(3):N75-N85 3.1.44 Regenerativa Simonetti S;Molina MA;Queralt C;de Aguirre I;Mayo C;Bertran-Alamillo J;Sanchez JJ;Gonzalez-Larriba JL;Jimenez U;Isla D;Moran T;Viteri S;Camps C;Garcia-Campelo R;Massuti B;Benlloch S;Cajal SRY;Taron M;Rosell R;.Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.Journal of Translational Medicine.2010;8 3.1.45 Rehabilitación Castilla E;Pascual I;Roncales F;Aguirre E;Del RA;.Transient response of cardiac angiosarcoma to paclitaxel.Eur J Cancer Care.2010;19(5):699-700 3.1.46 Respiratorio Arilla MC;Ibarrola I;Brena S;Martinez A;Colas C;Asturias JA;.The Russian Thistle (Salsola kali) Pollen Major Allergen, Sal k 1, Can Be Quantified in Allergenic Extracts and Airborne Pollen.Int Arch Allergy Imm.2010;152(4):319-326 Colas C;Cebrian-Perez JA;Muino-Blanco T;.Caffeine induces ram sperm hyperactivation independent of cAMP-dependent protein kinase.Int J Androl.2010;33(1):E187-E197 Ibanez MD;Navarro A;Sanchez MC;Rondon C;Montoro J;Mateu V;Lluch-Bernal M;Fernandez-Parra B;Dordal MT;Davila I;Conde J;Anton E;Colas C;Valero A;.Rhinitis and its Association With Asthma in Patients Under 14 Years of Age Treated in Allergy Departments in Spain.Journal of Investigational Allergology and Clinical Immunology.2010;20(5):402-406 Otero R;Uresandi F;Jimenez D;Cabezudo MA;Oribe M;Nauffal D;Conget F;Rodriguez C;Cayuela A;.Home treatment in pulmonary embolism.Thromb Res.2010;126(1):E1-E5 Valero A;Ferrer M;Baro E;Sastre J;Navarro AM;Marti-Guadano E;Davila I;del Cuvillo A;Colas C;Antepara I;Alonso J;Mola O;Izquierdo I;Mullol J;.Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis.Allergy.2010;65(12):1609-1613 3.1.47 Reumatología Naredo E;Batlle-Gualda E;Garcia-Vivar ML;Garcia-Aparicio AM;Fernandez-Sueiro JL;Fernandez-Prada M;Giner E;RodriguezGomez M;Pina MF;Medina-Luezas JA;Toyos FJ;Campos C;Gutierrez-Polo R;Ferrer MA;Martinez O;az-Torne C;Gonzalez T;Campos S;Queiro R;Castano-Sanchez M. Power Doppler Ultrasonography Assessment of Entheses in Spondyloarthropathies: Response to Therapy of Entheseal Abnormalities.Journal of Rheumatology.2010;37(10):2110-2117 3.1.48 Salud Mental Braam AW;Beekman ATF;Dewey ME;Delespaul PAEG;Fichter M;Lobo A;Magnusson H;Peres K;Reischies FM;Roelands M;Saz P;Schoevers RA;Skoog I;Copeland JRM;.Depression and parkinsonism in older Europeans: results from the EURODEP concerted action.Int J Geriatr Psyc.2010;25(7):679-687 Campayo A;de Jonge P;Roy JF;Saz P;de la Camara C;Quintanilla MA;Marcos G;Santabarbara J;Lobo A;.Depressive Disorder and Incident Diabetes Mellitus: The Effect of Characteristics of Depression.Am J Psychiat.2010;167(5):580-588 Gutierrez-Galve L;Wheeler-Kingshott CAM;Altmann DR;Price G;Chu EM;Leeson VC;Lobo A;Barker GJ;Barnes TRE;Joyce EM;Ron MA;.Changes in the Frontotemporal Cortex and Cognitive Correlates in First-Episode Psychosis.Biol Psychiat.2010;68(1):51-60 26
  26. 26. Lobo E;Dufouil C;Marcos G;Quetglas B;Saz P;Guallar E;Lobo A;.Is There an Association Between Low-to-Moderate Alcohol Consumption and Risk of Cognitive Decline?.Am J Epidemiol.2010;172(6):708-716 Ruiz-Lazaro PM;Comet MP;Calvo AI;Zapata M;Cebollada M;Trebol L;Lobo A;.Prevalence of eating disorders in early adolescent students.Actas Esp Psiquiatri.2010;38(4):204-211 Valldeoriola F;Regidor I;Minguez-Castellanos A;Lezcano E;Garcia-Ruiz P;Rojo A;Salvador A;Castro A;Grandas F;Kulisevsky J;Marti MJ;Martinez-Martin P;Relova L;Rumia J;Camara A;Burguera JA;Linazasoro G;de Val JL;Obeso J;Rodriguez-Oroz MC;Tolosa E;.Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study.Journal of Neurology Neurosurgery and Psychiatry.2010;81(1):65-69 3.1.49 Salud Pública y Servicios Sanitarios Aibar-Arregui MA;Matia-Sanz M;Pelay-Cacho R;Iguzquiza-Pellejero MJ;Martin-Fortea MP;Clavel-Conget L;Gomez-Del Valle C;Ruiz-Ruiz FJ;Sierra-Bergua B;.Nephritic colic management in an emergency room of a referral hospital.An Sist Sanit Navar.2010;33(2):145-15 Aibar MA;Laborda K;Conget F;Cornudella R;.Hypercoagulability state and endotelial injury in stable chronic obstructive pulmonary disease patients.An Sist Sanit Navar.2010;33(1):43-50 Carpenter KL, Duevel MA, Lee PW et al (Aibar C in working group). .Measures of patient safety in developing and emerging countries: a review of the literature.Qual Saf Health Care.2010;19:48-54 Castilla E;Pascual I;Roncales F;Aguirre E;Del RA;.Transient response of cardiac angiosarcoma to paclitaxel.Eur J Cancer Care.2010;19(5):699-700 Guijarro PM;Andres JMA;Mira JJ;Perdiguero E;Aibar C;.Adverse events in hospitals: the patient's point of view.Qual Saf Health Care.2010;19(2):144-147 Martinez RG;Ibanez AM;Gomez PC;Villanueva ACG;Bergareche IA;Jaime CG;.Abdominal Girth Utility as a Method of Metabolic Syndrome Screening in People with Hypertension.Revista Espanola De Salud Publica.2010;84(2):215-222 Olivera S;De Esealante B;Morandeira A;Val-Carreres P;Castillo MC;Castiella T;.Partial jejunal volvulus due to a mesenteric cystic lymphangioma.An Sist Sanit Navar.2010;33(3):323-326 Hospital Obispo Polanco 3.1.50 FI: 8,174 Cirugía Martin-Hernandez C;Cebamanos-Celma J;Molina-Ros A;Ballester-Jimenez JJ;Ballester-Soleda J;.Regenerated Cartilage Produced by Autogenous Periosteal Grafts: A Histologic and Mechanical Study in Rabbits Under the Influence of Continuous Passive Motion. Arthroscopy-The journal of arthroscopic and related surgery. 2010;26(1):76-83 3.1.51 Oviedo Enfermedades Infecciosas AM;Formento EA;Gil MJC;Burgui JAM;.Dengue fever: differential diagnosis of fever in travelers.Emergencias.2010;22(3):203-205 3.1.52 Medicina Interna Rodriguez A;Cipres L;Tofe S;Polavieja P;Reviriego J;.Clinical evaluation of combined therapy for type 2 diabetes.Curr Med Res Opin.2010;26(5):1171-1183 Lopez SZ;Vicario JM;Lerin FJ;Fernandez A;Perez G;Fonseca C;.Epstein-Barr Virus Myocarditis as the First Symptom of Infectious Mononucleosis.Internal Med.2010;49(6):569-571 3.1.53 Obstetricia y Ginecología Lazaro BE;Formento EA;.Emergency management of hurried obstetric labor and delivery.Emergencias.2010;22(2):140-143 27
  27. 27. 3.1.54 Oncología Roca JM;Alonso V;Pericay C;Escudero P;Salud A;Losa F;Lopez LJ;Guasch I;Mendez M;Quintero-Aldana G;Grande C;Vicente P;Arrivi A;Martin C;Moreno I;Garcia P;Anton I;Constenla M;Yubero A;Cirera L;.Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer.Chemotherapy.2010;56(2):142-146 3.1.55 Regenerativa Rodriguez A;Cipres L;Tofe S;Polavieja P;Reviriego J;.Clinical evaluation of combined therapy for type 2 diabetes.Curr Med Res Opin.2010;26(5):1171-1183 3.1.56 Traumatología Martin-Hernandez C;Cebamanos-Celma J;Molina-Ros A;Ballester-Jimenez JJ;Ballester-Soleda J;.Regenerated Cartilage Produced by Autogenous Periosteal Grafts: A Histologic and Mechanical Study in Rabbits Under the Influence of Continuous Passive Motion. Arthroscopy-The journal of arthroscopic and related surgery. 2010;26(1):76-83 Hospital Royo Villanova 3.1.57 FI: 35,003 Cardiovascular Almagro P;Garcia FL;Cabrera FJ;Montero L;Morchon D;Diez J;Soriano JB;.Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study.Resp Med.2010;104(2):253-259 3.1.58 Ciencia y Tecnología de los alimentos Gomez-Sanz E;Torres C;Lozano C;Fernandez-Perez R;Aspiroz C;Ruiz-Larrea F;Zarazaga M;.Detection, Molecular Characterization, and Clonal Diversity of Methicillin-Resistant Staphylococcus aureus CC398 and CC97 in Spanish Slaughter Pigs of Different Age Groups.Foodborne Pathogens and disease.2010;7(10):1269-1277 3.1.59 Cirugía Garcia-Alvarez F;Al-Ghanem R;Garcia-Alvarez I;Lopez-Baisson A;Bernal M;.Risk factors for postoperative infections in patients with hip fracture treated by means of Thompson arthroplasty.Arch Gerontol Geriat.2010;50(1):51-55 3.1.60 Digestivo Abuli A;Bessa X;Gonzalez JR;Ruiz-Ponte C;Caceres A;Munoz J;Gonzalo V;Balaguer F;Fernandez-Rozadilla C;Gonzalez D;de Castro L;Clofent J;Bujanda L;Cubiella J;Rene JM;Morillas JD;Lanas A;Rigau J;Garcia AM;Latorre M;Salo J;Banares FF;Arguello L;Pena E;Vilella.Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer Phenotype.Gastroenterology.2010;139(3):788-U129 Lucas MO;Peiro PS;Domingo JJS;.Irritable bowel syndrome immune hypothesis. Part one: the role of lymphocytes and mast cells.Rev Esp Enferm Dig.2010;102(11):637-647 Lucas MO;Peiro PS;Domingo JJS;.Irritable bowel syndrome immune hypothesis. Part two: the role of cytokines.Rev Esp Enferm Dig.2010;102(12):711-717 3.1.61 Enfermedades Infecciosas Aspiroz C;Gilaberte Y;Rezusta A;Boekhout T;Rubio MC;.Gentamycin inhibits the growth of Malassezia pachydermatis in culture.Revista Iberoamericana De Micologia.2010;27(1):20-21 Tubau F;Linares J;Rodriguez MD;Cercenado E;Aldea MJ;Gonzalez-Romo F;Torroba L;Berdonces P;Plazas J;Aguilar L;Delgado A;Garcia-Escribano N;.Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.Diagostic microbiology and infectious disease.2010;66(3).308-313 28
  28. 28. 3.1.62 Medicina Interna Almagro P;Garcia FL;Cabrera FJ;Montero L;Morchon D;Diez J;de la Iglesia F;Roca FB;Fernandez-Ruiz M;Castiella J;Zubillaga E;Recio J;Soriano JB;.Study of the comorbidities in hospitalized patients due to decompensated chronic obstructive pulmonary disease attended in the Internal Medicine Services. ECCO Study. Revista Clínica Española.2010;210(3):101-108 3.1.63 Microbiología Tubau F;Linares J;Rodriguez MD;Cercenado E;Aldea MJ;Gonzalez-Romo F;Torroba L;Berdonces P;Plazas J;Aguilar L;Delgado A;Garcia-Escribano N;.Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.Diagnostic microbiology and infectious disease.2010;66(3).308-313 3.1.64 Neurociencias Gracia-Naya M;Huerta-Villanuev M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;Artal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients. Revista de Neurologia.2010;50(9):513-519 Modrego PJ;Fayed N;Errea JM;Rios C;Pina MA;Sarasa M;.Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.Eur J Neurol.2010;17(3):405-412 3.1.65 Respiratorio Almagro P;Garcia FL;Cabrera FJ;Montero L;Morchon D;Diez J;Soriano JB;.Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study.Resp Med.2010;104(2):253-259 Dominguez A;Izquierdo C;Salleras L;Ruiz L;Sousa D;Bayas JM;Nebot M;Varona W;Celorrio JM;Carratala J;.Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly.Eur Respir J.2010;36(3):608-614 3.1.66 Salud Mental Arilla JA;Fernandez ME;Vinuales E;Lozano I;.Antipsychotic polypharmacy in a general hospital in-patient psychiatric unit.Revista De Psiquiatria Y Salud Mental.2010;3(3):90-96 3.1.67 Salud Pública Izquierdo C;Oviedo M;Ruiz L;Sintes X;Vera I;Nebot M;Bayas JM;Carratala J;Varona W;Sousa D;Celorrio JM;Salleras L;Dominguez A;.Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study.BMC Public Health.2010;10 Hospital San Jorge 3.1.68 FI: 149,954 Biofísica Gonzalez S;Gilaberte Y;Philips N;.Mechanistic insights in the use of a Polypodium leucotomos extract as an oral and topical photoprotective agent.Photoch Photobio Sci.2010;9(4):559-563 3.1.69 Bioquímica y Biología molecular Gonzalez S;Gilaberte Y;Philips N;.Mechanistic insights in the use of a Polypodium leucotomos extract as an oral and topical photoprotective agent.Photoch Photobio Sci.2010;9(4):559-563 3.1.70 Cardiovascular Puzo J;Alfonso P;Irun P;Gervas J;Pocovi M;Giraldo P;.Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.Atherosclerosis.2010;209(2):515-519 29
  29. 29. Sole-Violan J;de Castro FR;Garcia-Laorden MI;Blanquer J;Aspa J;Borderias L;Briones ML;Rajas O;Carrondo IML;Marcos-Ramos JA;Aguero JMF;Garcia-Saavedra A;Fiuza MD;Caballero-Hidalgo A;Rodriguez-Gallego C;.Genetic variability in the severity and outcome of community-acquired pneumonia.Respiratory Medicine.2010;104(3):440-447 3.1.71 Dermatología Gilaberte Y;Frias MP;Perez-Lorenz JB;.Chondrodermatitis Nodularis Helicis Successfully Treated With Photodynamic Therapy.Arch Dermatol.2010;146(10):1080-1082 Gonzalez S;Gilaberte Y;Philips N;.Mechanistic insights in the use of a Polypodium leucotomos extract as an oral and topical photoprotective agent.Photoch Photobio Sci.2010;9(4):559-563 Gonzalez S;Philips N;Gilaberte Y;.Photoprotection: update in UV-filter molecules, the 'new wave' of sunscreens.Giornale Italiano Di Dermatologia E Venereologia.2010;145(4):515-523 3.1.72 Genética Kiemeney LA;Sulem P;Besenbacher S;Vermeulen SH;Sigurdsson A;Thorleifsson G;Gudbjartsson DF;Stacey SN;Gudmundsson J;Kostic J;Masson G;Bjarnason H;Palsson ST;Skarphedinsson OB;Gudjonsson SA;Witjes JA;Grotenhuis AJ;Verhaegh GW;Bishop DT;Sak SC;Choudhury A;. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nature Genetics.2010;42(5):415-U67 3.1.73 Hematología Puzo J;Alfonso P;Irun P;Gervas J;Pocovi M;Giraldo P;.Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.Atherosclerosis.2010;209(2):515-519 Silverman LB;Supko JG;Stevenson KE;Woodward C;Vrooman LM;Neuberg DS;Asselin BL;Athale UH;Clavell L;Cole PD;Kelly KM;Laverdiere C;Michon B;Schorin M;Schwartz CL;O'Brien JE;Cohen HJ;Sallan SE;.Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.Blood.2010;115(13):13511353 3.1.74 Enfermedades Infecciosas Aspiroz C;Gilaberte Y;Rezusta A;Boekhout T;Rubio MC;.Gentamycin inhibits the growth of Malassezia pachydermatis in culture.Revista Iberoamericana De Micologia.2010;27(1):20-21 Peralta PSO;Vazquez-Torres MC;Latorre-Fandos E;Mairal-Claver P;Cortina-Solano P;Puy-Azon A;Sancho BA;Leitmeyer K;Lucientes-Curdi J;Sierra-Moros MJ;.First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010.Eurosurveillance. 2010;15(41):2-4 3.1.75 Medicina Interna Garrido A;Iborra MI;Saperas E;de Sousa M;.Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors.Med Clin-barcelona.2010;134(13):577-582 3.1.76 Neurociencias Gazulla J;Benavente I;Lopez-Fraile IP;Tordesillas C;Modrego P;Alonso I;Pinto-Basto J;.Sensory neuronopathy in ataxia with oculomotor apraxia type 2.J Neurol Sci.2010;298(01-feb):118-120 Gracia-Naya M;Huerta-Villanuev M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;rtal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients.Revista de neurología.2010;50(9):513-519 Revilla I;Segura LY;Arrillaga AGP;Suarez PB;.Attitudes of the family toward the mentally ill patient.Actas Esp Psiquiatri.2010;38(1):57-64 30
  30. 30. 3.1.77 Respiratorio Borderias L;Morell F;Vera J;Briz H;Munoz X;Cruz MJ;.Starling-Induced Hypersensitivity Pneumonitis: Minimal but Persistent Antigen Exposure.Arch Bronconeumol.2010;46(11):607-609 Portillo K;Santos S;Madrigal I;Blanco I;Pare C;Borderias L;Peinado VI;Roca J;Mila M;Barbera JA;.Study of the BMPR2 Gene in Patients with Pulmonary Arterial Hypertension.Arch Bronconeumol.2010;46(3):129-134 Sole-Violan J;de Castro FR;Garcia-Laorden MI;Blanquer J;Aspa J;Borderias L;Briones ML;Rajas O;Carrondo IML;Marcos-Ramos JA;Aguero JMF;Garcia-Saavedra A;Fiuza MD;Caballero-Hidalgo A;Rodriguez-Gallego C;.Genetic variability in the severity and outcome of community-acquired pneumonia.Respiratory Medicine.2010;104(3):440-447 Soriano JB;Miravitlles M;Borderias L;Duran-Tauleria E;Rio FG;Martinez J;Montemayor T;Munoz L;Pineiro L;Sanchez G;Serra J;Soler-Cataluna JJ;Torres A;Viejo JL;Sobradillo-Pena V;Ancochea J;.Geographical Variations in the Prevalence of COPD in Spain: Relationship to Smoking, Death Rates and other Determining Factors.Archivos de Bronconeumología.2010;46(10):522-530 3.1.78 Reumatología Garcia-Doval I;Perez-Zafrilla B;Descalzo MA;Rosello R;Hernandez MV;Gomez-Reino JJ;Carmona L;.Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists.Ann Rheum Dis.2010;69(10):17 3.1.79 Revilla Salud Mental I;Segura LY;Arrillaga AGP;Suarez PB;.Attitudes of the family toward the mentally ill patient.Actas Esp Psiquiatri.2010;38(1):57-64 3.1.80 Salud Pública Fajo-Pascual M;Godoy P;Ferrero-Cancer M;Wymore K;.Case-control study of risk factors for sporadic Campylobacter infections in northeastern Spain.Eur J Public Health.2010;20(4):443-448 Hospital Universitario Miguel Servet 3.1.81 FI: 433,859 Alergología Ibero M;Bone J;Martin B;Martinez J;.Evaluation of an extensively hydrolysed casein formula (Damira 2000 (R)) in children with allergy to cow's milk proteins.Allergol Immunopath.2010;38(2):60-68 3.1.82 Anatomía Patológica Pagni F;Zarate AF;Urbanski SJ;.Necrotizing Sialometaplasia of Bronchial Mucosa.Int J Surg Pathol.2010;18(1):64-65 Matarraz S;Lopez A;Barrena S;Fernandez C;Jensen E;Flores-Montero J;Rasillo A;Sayagues JM;Sanchez ML;Barcena P;Hernandez-Rivas JM;Salvador C;Fernandez-Mosteirin N;Giralt M;Perdiguer L;Laranjeira P;Paiva A;Orfao A;.Bone Marrow Cells from Myelodysplastic Syndromes Show Altered Immunophenotypic Profiles That May Contribute to the Diagnosis and Prognostic Stratification of the Disease: a Pilot Study on A Series of 56 Patients.Cytometry partB-clinical cytometry.2010;78B(3):154-168 3.1.83 Atención Primaria Fayed N;Garcia-Campayo J;Magallon R;ndres-Bergareche H;Luciano JV;Andres E;Beltran J;.Localized H-1-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and Nacetylaspartate.Arthritis Research & Therapy.2010;12(4): 3.1.84 Biología Fernandez-Vizarra E;Ferrin G;Perez-Martos A;Fernandez-Silva P;Zeviani M;Enriquez JA;.Isolation of mitochondria for biogenetical studies: An update.Mitochondrion.2010;10(3):253-262 31
  31. 31. 3.1.85 Bioquímica y biología molecular Martin P;Pardo J;Schill N;Jockel L;Berg M;Froelich CJ;Wallich R;Simon MM;.Granzyme B-induced and caspase 3-dependent cleavage of gelsolin by mouse cytotoxic T cells modifies cytoskeleton dynamics.J Biol Chem.2010;285(24):18918-18927 3.1.86 Biotecnología Lavilla M;Marzo I;de Luis R;Perez MD;Calvo M;Sanchez L;.Detection of Clostridium tyrobutyricum spores using polyclonal antibodies and flow cytometry.J Appl Microbiol.2010;108(2):488-498 3.1.87 Cardiovascular Burillo E;Andres EM;Mateo-Gallego R;Fiddyment S;Jarauta E;Cenarro A;Civeira F;.High-density lipoprotein cholesterol increase and non-cardiovascular mortality: a meta-analysis.Heart.2010;96(17):1345-1351 Cabre A;Lazaro I;Cofan M;Jarauta E;Plana N;Garcia-Otin AL;Ascaso JF;Ferre R;Civeira F;Ros E;Masana L;.FABP4 plasma levels are increased in familial combined hyperlipidemia.J Lipid Res.2010;51(5):1173-1178 Hollak CEM;vom Dahl S;Aerts JMFG;Belmatoug N;Bembi B;Cohen Y;Collin-Histed T;Deegan P;van Dussen L;Giraldo P;Mengel E;Michelakakis H;Manuel J;Hrebicek M;Parini R;Reinke J;di Rocco M;Pocovi M;Miranda MCS;Tylki-Szymanska A;Zimran A;Cox TM;.Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease.Blood Cells Molecules and Diseases.2010;44(1):41-47 Junyent M;Gilabert R;Jarauta E;Nunez I;Cofan M;Civeira F;Pocovi M;Mallen M;Zambon D;Almagro F;Vega J;Tejedor D;Ros E;.Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.Atherosclerosis.2010;208(2):437-441 Martin B;Solanas-Barca M;Garcia-Otin AL;Pampin S;Cofan M;Ros E;Rodriguez-Rey JC;Pocovi M;Civeira F;.An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia.Nutr Metab Cardiovas.2010;20(4):236-242 Mateo-Gallego R;Calmarza P;Jarauta E;Burillo E;Cenarro A;Civeira F;.Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia.Metabolism.2010;59(2):154-158 Mateo-Gallego R;Solanas-Barca M;Burillo E;Cenarro A;Marques-Lopes I;Civeira F;.Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia.J Physiol Biochem.2010;66(3):229-236 Puzo J;Alfonso P;Irun P;Gervas J;Pocovi M;Giraldo P;.Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.Atherosclerosis.2010;209(2):515-519 Robles NR;Ocon J;Gomez CF;Manjon M;Pastor L;Herrera J;Villatoro J;Calls J;Torrijos J;Rodriguez VI;Rodriguez MMA;Mendez ML;Morey A;Martinez FI;Marco J;Liebana A;Rincon B;Tornero F;.Lercanidipine in patients with chronic renal failure: the ZAFRA Study.Cardiovascular Therapy and Prevention.2010;9(4):81-87 Sala-Vila A;Cofan M;Perez-Heras A;Nunez I;Gilabert R;Junyent M;Mateo-Gallego R;Cenarro A;Civeira F;Ros E;.Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia.Am J Clin Nutr.2010;92(1):186-193 Tejedor MT;Cenarro A;Tejedor D;Stef M;Mateo-Gallego R;de Castro I;Garcia-Otin AL;Monteagudo LV;Civeira F;Pocovi M;.Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene.Mol Genet Genomics.2010;283(6):565-574 Zambon D;Quintana M;Mata P;Alonso R;Benavent J;Cruz-Sanchez F;Gich J;Pocovi M;Civeira F;Capurro S;Bachman D;Sambamurti K;Nicholas J;Pappolla MA;.Higher Incidence of Mild Cognitive Impairment in Familial Hypercholesterolemia.Am J Med.2010;123(3):267-274 3.1.88 Cirugía Crespo-Leiro MG;Delgado JF;Paniagua MJ;de Prada JAV;Fernandez-Yanez J;Almenar L;az-Molina B;Roig E;Arizon JM;onsoPulpon L;Garrido IP;Sanz ML;de la Fuente L;Mirabet S;Manito N;Muniz J;.Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study.Clinical Transplantation.2010;24(4):E88-E93 32
  32. 32. Delgado JF;Crespo-Leiro MG;Gomez-Sanchez MA;Paniagua MJ;Gonzalez-Vilchez F;de Prada JAV;Fernandez-Yanez J;Pascual D;Almenar L;Martinez-Dolz L;Diaz B;Roig E;Segovia J;Arizon JM;Garrido I;Blasco T;Lopez J;Brossa V;Manito N;Muniz J;.Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study.Clinical Transplantation.2010;24(5):E194-E200. Gutierrez-Dalmau A;Revuelta I;Ferrer B;Mascaro JM;Oppenheimer F;Albanell J;Campistol JM;.Distinct Immunohistochemical Phenotype of Nonmelanoma Skin Cancers Between Renal Transplant and Immunocompetent Populations.Transplantation.2010;90(9):986-992 Pagni F;Zarate AF;Urbanski SJ;.Necrotizing Sialometaplasia of Bronchial Mucosa.Int J Surg Pathol.2010;18(1):64-65 3.1.89 Digestivo Fernandez-Rodriguez CM;Alonso S;Martinez SM;Forns X;Sanchez-Tapias JM;Rincon D;Rodriguez-Caravaca G;Barcena R;Serra MA;Romero-Gomez M;Fernandez I;Garcia-Samaniego J;Fuente J;Sola R;Moreno-Otero R;Planas R;.Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response.American Journal of Gastroenterology.2010;105(10):2164-2172 Mearin F;Balboa A;Castells A;Dominguez JE;Esteve M;Garcia-Erce JA;Gisbert JP;Gomollon F;Panes J;Ponce J;.Iron deficiency anemia and use of intravenous iron in digestive disease.Gastroenterologia Y Hepatologia.2010;33(8):605-613 Uribarrena-Amezaga R;Ortego J;Fuentes J;Raventos N;Parra P;Uribarrena-Echevarria R;.Prognostic value of lymph node micrometastases in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0).Rev Esp Enferm Dig.2010;102(3):176-181 3.1.90 Endocrinología y metabolismo Altirriba J;Gasa R;Casas S;Ramirez-Bajo MJ;Ros S;Gutierrez-Dalmau A;de Villa MCR;Barbera A;Gomis R;.The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker.Diabetologia.2010;53(7):1406-1414 Luque-Ramirez M;Portoles GR;Varela C;Albero R;Halperin I;Moreiro J;Soto A;Casamitjana R;.The Efficacy of Octreotide LAR as Firstline Therapy for Patients with Newly Diagnosed Acromegaly is Independent of Tumor Extension: Predictive Factors of Tumor and Biochemical Response.Hormone and metabolic research.2010;42(1):38-44. 3.1.91 Enfermedades infecciosas Aspiroz C;Gilaberte Y;Rezusta A;Boekhout T;Rubio MC;.Gentamycin inhibits the growth of Malassezia pachydermatis in culture.Revista Iberoamericana De Micologia.2010;27(1):20-21 Betran A;Villuendas MC;Rezusta A;Moles B;Rubio MC;Revillo MJ;Boiron P;Bello S;Rodriguez-Nava V;.Cavitary Pneumonia Caused by Nocardia Otitidiscaviarum.Braz J Microbiol.2010;41(2):329-332 Najafzadeh MJ;Rezusta A;Cameo MI;Zubiri ML;Yus MC;Badali H;Revillo MJ;De Hoog GS;.Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.Med Mycol.2010;48(2):390-393 Roc ML;Palacian MP;Lomba E;Monforte ML;Rebaje V;Pinilla MJR;.Serologic diagnosis of congenital toxoplasmosis.Enferm Infec Micr Cl.2010;28(8):517-519 3.1.92 Genética Fernandez-Vizarra E;Ferrin G;Perez-Martos A;Fernandez-Silva P;Zeviani M;Enriquez JA;.Isolation of mitochondria for biogenetical studies: An update.Mitochondrion.2010;10(3):253-262 3.1.93 Hematología Alvarez-Larran A;Cervantes F;Pereira A;rellano-Rodrigo E;Perez-Andreu V;Hernandez-Boluda JC;Ayats R;Salvador C;Muntanola A;Bellosillo B;Vicente V;Hernandez-Nieto L;Burgaleta C;Xicoy B;Besses C;.Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia.Blood.2010;116(8):1205-1210 33
  33. 33. Biegstraaten M;Mengel E;Marodi L;Petakov M;Niederau C;Giraldo P;Hughes D;Mrsic M;Mehta A;Hollak CEM;van Schaik IN;.Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.Brain.2010;133:2909-2919 Chillon MC;Santamaria C;Garcia-Sanz R;Balanzategui A;Sarasquete ME;Alcoceba M;Marin L;Caballero MD;Vidriales MB;Ramos F;Bernal T;az-Mediavilla J;de Coca AG;Penarrubia MJ;Queizan JA;Giraldo P;San Miguel JF;Gonzalez M;.Long FLT3 internal tandem duplications and reduced PML-RAR alpha expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.Hematologica-The hematology journal.2010;95(5):745-751 Hollak CEM;vom Dahl S;Aerts JMFG;Belmatoug N;Bembi B;Cohen Y;Collin-Histed T;Deegan P;van Dussen L;Giraldo P;Mengel E;Michelakakis H;Manuel J;Hrebicek M;Parini R;Reinke J;di Rocco M;Pocovi M;Miranda MCS;Tylki-Szymanska A;Zimran A;Cox TM;.Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease.Blood cells molecules and diseases.2010;44(1):41-47 Marcos-Gragera R;Cervantes-Amat M;Vicente ML;de Sanjose S;Guallar E;Godoy C;Calvo C;Giraldo P;Sant M;Peris-Bonet R;Martos MC;.Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002).Eur J Cancer Prev.2010;19(4):247-255 Matarraz S;Lopez A;Barrena S;Fernandez C;Jensen E;Flores-Montero J;Rasillo A;Sayagues JM;Sanchez ML;Barcena P;Hernandez-Rivas JM;Salvador C;Fernandez-Mosteirin N;Giralt M;Perdiguer L;Laranjeira P;Paiva A;Orfao A;.Bone Marrow Cells from Myelodysplastic Syndromes Show Altered Immunophenotypic Profiles That May Contribute to the Diagnosis and Prognostic Stratification of the Disease: a Pilot Study on A Series of 56 Patients.Cytometry part B-clinical cytometry.2010;78(3):154-168 Oriol A;Vives S;Hernandez-Rivas JM;Tormo M;Heras I;Rivas C;Bethencourt C;Moscardo F;Bueno J;Grande C;del Potro E;Guardia R;Brunet S;Bergua J;Bernal T;Moreno MJ;Calvo C;Bastida P;Feliu E;Ribera JM;.Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.Haematologica-the hematology journal.2010;95(4):589-596 Perez Delgado R;Lafuente Hidalgo M;Lopez Pison J;Sebastian Torres B;Torres Claveras S;Garcia Jimenez MC;Baldellou Vazquez A;Pena Segura JL;.Epilepsy onset between one month and three months of life: Our 11 years experience.Neurologia.2010;25(2):90-95 Pie J;Gil-Rodriguez MC;Ciero M;Lopez-Vinas E;Ribate MP;Arnedo M;Deardorff MA;Puisac B;Legarreta J;de Karam JC;Rubio E;Bueno I;Baldellou A;Calvo MT;Casals N;Olivares JL;Losada A;Hegardt FG;Krantz ID;Gomez-Puertas P;Ramos FJ;.Mutations and Variants in the Cohesion Factor Genes NIPBL, SMC1A, and SMC3 in a Cohort of 30 Unrelated Patients With Cornelia de Lange Syndrome.American Journal of medical genetics.2010;152(4):924-929 Puzo J;Alfonso P;Irun P;Gervas J;Pocovi M;Giraldo P;.Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.Atherosclerosis.2010;209(2):515-519 Santamaria C;Chillon MC;Garcia-Sanz R;Perez C;Caballero MD;Mateos MV;Ramos F;de Coca AG;Alonso JM;Giraldo P;Bernal T;Queizan JA;Rodriguez JN;Puig N;Balanzategui A;Sarasquete ME;Alcoceba M;az-Mediavilla J;San Miguel J;Gonzalez M;.BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).Annals of hematology.2010,89(5):453-458 Urreizti R;Moya-Garcia AA;Pino-Angeles A;Cozar M;Langkilde A;Fanhoe U;Esteves C;Arribas J;Vilaseca MA;Perez-Duenas B;Pineda M;Gonzalez V;Artuch R;Baldellou A;Vilarinho L;Fowler B;Ribes A;Sanchez-Jimenez F;Grinberg D;Balcells S;.Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency.Clinical Genetics.2010;78(5):441-448 3.1.94 Ingeniería Biomédica E. Gil, J.M. Vergara, and P. Laguna.Pulse Transit Time Variability versus Heart Rate Variability during Decreases in the Amplitude fluctuations of Photoplethysmography signal.International Journal Of Bioelectromagnetism .2010;12(3):95-101 Gracia L;Ibarz E;Puertolas S;Cegonino J;Lopez-Prats F;Panisello JJ;Herrera A;.Study of bone remodeling of two models of femoral cementless stems by means of DEXA and finite elements.Biomed Eng Online.2010;9 Puertolas S;Perez-Garcia JM;Gracia L;Cegonino J;Ibarz E;Puertolas JA;Herrera A;.Design of splints based on the NiTi alloy for the correction of joint deformities in the fingers.Biomed Eng Online.2010;9 34
  34. 34. 3.1.95 Inmunología Gutierrez-Dalmau A;Revuelta I;Ferrer B;Mascaro JM;Oppenheimer F;Albanell J;Campistol JM;.Distinct Immunohistochemical Phenotype of Nonmelanoma Skin Cancers Between Renal Transplant and Immunocompetent Populations.Transplantation.2010;90(9):986-992 Ibero M;Bone J;Martin B;Martinez J;.Evaluation of an extensively hydrolysed casein formula (Damira 2000 (R)) in children with allergy to cow's milk proteins.Allergol Immunopath.2010;38(2):60-68 3.1.96 Medicina Interna Ambroj CM;Osuna JGG;Lezcano JSR;Cebollero IC;Gracia MCF;Peralta LJP;.Acute reperfusion therapy in elderly women with acute myocardial infarction with ST-segment elevation: efficacy in the reduction of their mortality.Med Clin- barcelona.2010;134(8):333-339 Duran-Cantolla J;Aizpuru F;Montserrat JM;Ballester E;Teran-Santos J;Aguirregomoscorta JI;Gonzalez M;Lloberes P;Masa JF;De la Pena M;Carrizo S;Mayos M;Barbe F;.Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.British Medical Journal.2010;341 Mendoza MA;Ruiz FJM;Lasfuentes PC;Aznarez HN;Espanol AP;Hernandez MJR;.Tumour necrosis factor alpha antagonists in established rheumatoid arthritis: Effectiveness comparative study.Med Clin-barcelona.2010;134(15):665-670 3.1.97 Microbiología Lavilla M;Marzo I;de Luis R;Perez MD;Calvo M;Sanchez L;.Detection of Clostridium tyrobutyricum spores using polyclonal antibodies and flow cytometry.J Appl Microbiol.2010;108(2):488-498 Roc ML;Palacian MP;Lomba E;Monforte ML;Rebaje V;Pinilla MJR;.Serologic diagnosis of congenital toxoplasmosis.Enferm Infec Micr Cl.2010;28(8):517-519 3.1.98 Neurociencias Almarcegui C;Dolz I;Pueyo V;Garcia E;Fernandez FJ;Martin J;Ara JR;Honrubia F;.Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients.Neurophysiol Clin.2010;40(3):129-135 Garcia-Martin E;Pueyo V;Martin J;Almarcegui C;Ara JR;Dolz I;Honrubia FM;Fernandez FJ;.Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis.Eur J Ophthalmol.2010;20(1):167-173 Gazulla J;Benavente I;Lopez-Fraile IP;Tordesillas C;Modrego P;Alonso I;Pinto-Basto J;.Sensory neuronopathy in ataxia with oculomotor apraxia type 2.J Neurol Sci.2010;298(01-feb):118-120 Gracia-Naya M;Huerta-Villanuev M;Rios-Gomez C;Latorre-Jimenez AM;Sanchez-Valiente S;Santos-Lasaosa S;Mauri-Llerda JA;Garcia-Gomara MJ;rtal-Roy J;.Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients.Revista de neurología.2010;50(9):513-519 Hernandez JMDT;Alfonso F;Gimeno F;Diarte JA;Lopez-Palop R;de Prado AP;Rivero F;Sanchis J;Larman M;Diaz JF;Elizaga J;Moreiras JM;Jaume AG;Hernandez JM;Mauri J;Recalde AS;Bullones JA;Rumoroso JR;del Blanco BG;Baz JA;Bosa F;Botas J;Hernandez F;.Thrombosis of Second-Generation Drug-Eluting Stents in Real Practice Results From the Multicenter Spanish Registry ESTROFA-2 (Estudio Espanol Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2). JaccCardiovascular interventions.2010;3(9):911-919 Lull N;Noe E;Lull JJ;Garcia-Panach J;Garcia-Marti G;Chirivella J;Ferri J;Sopena R;de La Cueva L;Robles M;.Thalamic metabolism and neurological outcome after traumatic brain injury. A voxel-based morphometric FDG-PET study.Neurologia.2010;25(3):174180 Modrego PJ;.Depression in Alzheimer's Disease. Pathophysiology, Diagnosis, and Treatment.J Alzheimers Dis.2010;21(4):10771087 Modrego PJ;Fayed N;Errea JM;Rios C;Pina MA;Sarasa M;.Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.Eur J Neurol.2010;17(3):405-412 35
  35. 35. Pascual-Gomez J;Gracia-Naya M;Leira R;Mateos V;varo-Gonzalez LC;Hernando I;Oterino A;Iglesias-Diez F;Caminero A;GarciaMonco JC;Forcea N;Guerrero-Peral AL;Bueno V;Santos-Garcia D;Perez C;Blanco M;Pego-Reigosa R;Rodriguez R;MedererHengstl S;Pato-Pato A;. Zonisamide in the preventive treatment of refractory migraine.Revista de neurología.2010;50(3):129-132 Pueyo V;Ara JR;Almarcegui C;Martin J;Guerri N;Garcia E;Pablo LE;Honrubia FM;Fernandez FJ;.Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis.Acta Ophthalmol.2010;88(7):748-752 Sanchez-Carteyron A;Alarcia R;Ara JR;Martin J;.Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.Neurology.2010;74(18):1471-1473 3.1.99 Obstetricia y Ginecología Medel JM;Mateo SC;Conde CR;Esque ACC;Mitchell MJR;.Spontaneous uterine rupture caused by placenta percreta at 18 weeks' gestation after in vitro fertilization.J Obstet Gynaecol Re.2010;36(1):170-173 3.1.100 Oftalmología Almarcegui C;Dolz I;Pueyo V;Garcia E;Fernandez FJ;Martin J;Ara JR;Honrubia F;.Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients.Neurophysiol Clin.2010;40(3):129-135 Cuenca N;Pinilla I;Fernandez-Sanchez L;Salinas-Navarro M;arcon-Martinez L;viles-Trigueros M;de la Villa P;de Imperial JM;Villegas-Perez MP;Vidal-Sanz M;.Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice.Experimental eye research.2010;91(2):273-285 Fernandez-Barrientos Y;Garcia-Feijoo J;Martinez-de-la-Casa J;Pablo LE;Fernandez-Perez C;Sanchez JG;.Fluorophotometric Study of the Effect of the Glaukos Trabecular Microbypass Stent on Aqueous Humor Dynamics.Invest Ophth Vis Sci.2010;51(7):3327-3332 Figus M;Fogagnolo P;Lazzeri S;Capizzi F;Romagnoli M;Canovetti A;Iester M;Ferreras A;Rossetti L;Nardi M;.Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.Eur J Ophthalmol.2010;20(5):811-818 Fogagnolo P;Capizzi F;Orzalesi N;Figus M;Ferreras A;Rossetti L;.Can Mean Central Corneal Thickness and Its 24-hour Fluctuation Influence Fluctuation of Intraocular Pressure?.J Glaucoma.2010;19(6):418-423 Fogagnolo P;Figus M;Frezzotti P;Iester M;Oddone F;Zeppieri M;Ferreras A;Brusini P;Rossetti L;Orzalesi N;.Test-retest variability of intraocular pressure and ocular pulse amplitude for dynamic contour tonometry: a multicentre study.Brit J Ophthalmol.2010;9 Garcia-Martin E;Pueyo V;Martin J;Almarcegui C;Ara JR;Dolz I;Honrubia FM;Fernandez FJ;.Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis.Eur J Ophthalmol.2010;20(1):167-173 Garcia-Martin E;Idoipe M;Gil LM;Pueyo V;Alfaro J;Pablo LE;Zubiri ML;Fernandez J;.Efficacy and Tolerability of Imiquimod 5% Cream to Treat Periocular Basal Cell Carcinomas.J Ocul Pharmacol Th.2010;26(4):373-379 Julvez LP;Sanchez JBD;Feijoo JG;Rubio-Terres C;.Methodologic Quality of Studies on Prognostic Factors for Primary Openangle Glaucoma Progression Measured by Visual Field Deterioration.J Glaucoma.2010;19(9):587-591 Pablo LE;Ferreras A;Pajarin AB;Fogagnolo P;.Diagnostic ability of a linear discriminant function for optic nerve head parameters measured with optical coherence tomography for perimetric glaucoma.Eye.2010;24(6):1051-1057 Pablo LE;Ferreras A;Fogagnolo P;Figus M;Pajarin AB;.Optic nerve head changes in early glaucoma: a comparison between stereophotography and Heidelberg retina tomography.Eye.2010;24(1):123-130 Pablo LE;Larrosa JM;Polo V;Ferreras A;Alias EG;Honrubia FM;.Performance of GDx and HRT in the Finnish Evidence-Based Guideline for Open-Angle Glaucoma.Eye.2010;24(2):297-303 Pueyo V;Ara JR;Almarcegui C;Martin J;Guerri N;Garcia E;Pablo LE;Honrubia FM;Fernandez FJ;.Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis.Acta Ophthalmol.2010;88(7):748-752 Ruiz MA;Pardo A;de la Casa JMM;Polo V;Esquiro J;Soto J;.Development of a Specific Questionnaire Measuring Patient Satisfaction with Glaucoma Treatment: Glausat.Ophthal Epidemiol.2010;17(3):131-143 Sanchez-Cano A;Pablo LE;Larrosa JM;Polo V;.The Effect of Phacoemulsification Cataract Surgery on Polarimetry and Tomography Measurements for Glaucoma Diagnosis.J Glaucoma.2010;19(7):468-474 36
  36. 36. 3.1.101 Oncología Anton A;Lluch A;Casado A;Provencio M;Munoz M;Lao J;Bermejo B;Paules AB;Gayo J;Martin M;.Phase I Study of Oral Vinorelbine and Capecitabine in Patients with Metastatic Breast Cancer.Anticancer Res.2010;30(6):2255-2261 Artal CA;Domine GM;Font PA;Garcia CR;Cobo DM;Isla CD;.SEOM clinical guidelines for the treatment of small-cell lung cancer.Clin Transl Oncol.2010;12(1):27-31 Bellmunt J;Maroto-Rey P;Trigo JM;Carles J;Guillem V;Lopez-Martin JA;nton-Torres A;Urruticoechea L;.A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01.Clinical&translational oncology.2010;12(7):503-508 Fernandez-Martos C;Pericay C;Aparicio J;Salud A;Safont M;Massuti B;Vera R;Escudero P;Maurel J;Marcuello E;Mengual JL;Saigi E;Estevan R;Mira M;Polo S;Hernandez A;Gallen M;Arias F;Serra J;Alonso V;.Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study.Journal of clinical oncology.2010;28(5):859-865 Garcia-Carbonero R;Capdevila J;Crespo-Herrero G;az-Perez JA;del Prado MPM;Orduna VA;Sevilla-Garcia I;Villabona-Artero C;Beguiristain-Gomez A;Llanos-Munoz M;Marazuela M;varez-Escola C;Castellano D;Vilar E;Jimenez-Fonseca P;Teule A;SastreValera J;Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEPNETs): results from the National Cancer Registry of Spain (RGETNE).Annals of oncology.2010;21(9):1794-1803 Garcia-Carbonero R;Espana MAG;Saenz EC;Orduna VA;Ruiperez AC;Plazas JG;Alfonso PG;Martel IJ;Flores EG;Garrido ML;Casado DI;.SEOM clinical guidelines for the treatment of advanced colorectal cancer.Clin Transl Oncol.2010;12(11):729-734 Martin-Broto J;Gutierrez A;Garcia-del-Muro X;Lopez-Guerrero JA;Martinez-Trufero J;de Sande LM;Lainez N;Maurel J;De Juan A;Losa F;Andres R;Casado A;Tejido PG;Blanco R;Carles J;Bellmunt J;Gomez-Espana A;Ramos R;Martinez-Serra J;LlombartBosch A;Poveda A;.Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.Annals of oncology.2010;21(7):1552-1557 Martin M;Segui MA;Anton A;Ruiz A;Ramos M;Adrover E;Aranda I;Rodriguez-Lescure A;Grosse R;Calvo L;Barnadas A;Isla D;del Prado PM;Borrego M;Zaluski J;Arcusa A;Munoz M;Vega JM;Mel JR;Munarriz B;Llorca C;Jara C;Alba E;Florian J;Li JF;GarciaAsenjo JA;Saez A;Rios M.Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.2010;363(23):2200-2210 Martinez-Trufero J;Alfaro J;Felipo F;Alvarez M;Madani J;Cebollero A;.Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma.Anti-cancer Drug.2010;21(8):795-798 Martinez-Trufero J;Isla D;Adansa JC;Irigoyen A;Hitt R;Gil-Arnaiz I;Lambea J;Lecumberri MJ;Cruz JJ;.Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment.British Journal of Cancer.2010;102(12):1687-1691 Maurel J;Martins AS;Poveda A;Lopez-Guerrero JA;Cubedo R;Casado A;Martinez-Trufero J;Ayuso JR;Lopez-Pousa A;GarciaAlbeniz X;del Muro XG;de Alava E;.Imatinib Plus Low-Dose Doxorubicin in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to High-Dose Imatinib A Phase I-II Study by the Spanish Group for Research on Sarcomas.Cancer.2010;116(15):3692-3701 Milne RL;Osorio A;Cajal TRY;Baiget M;Lasa A;az-Rubio E;de la Hoya M;Caldes T;Teule A;Lazaro C;Blanco I;Balmana J;Sanchez-Olle G;Vega A;Blanco A;Chirivella I;Cardenosa EE;Duran M;Velasco E;de Duenas EM;Tejada MI;Miramar MD;Calvo MT;Guillen-Ponce C;Salazar.Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.Breast cancer research and treatment.2010;119(1):221-232 Provencio M;de Las Penas R;Camps C;Artal A;Massuti B;Cobo M;Perez FJ;Sanchez A;Rosell R;.Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?.Lung Cancer.2010;68(3):415-419 Puente J;Lopez-Tarruella S;Ruiz A;Lluch A;Pastor M;Alba E;de la Haba J;Ramos M;Cirera L;Anton A;Llombart A;Plazaola A;Fernandez-Aramburo A;Sastre J;az-Rubio E;Martin M;.Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register.Breast Cancer research and treatment. 2010;122(2):591-600 37

×